000	precipitated	1
000	SM1,	1
000	protrusion.	1
000	SNF11	1
000	retarded	1
000	rhp51+,	1
000	interact,	1
000	rdh54Delta	1
000	stereociliary	1
000	metastasis,	1
000	non-polyposis	1
000	Ser-133	1
000	C-induced	1
000	(beta-cat)	1
000	polymerase,	1
000	covalent	1
000	kidneys,	1
000	73	1
000	signaling.	1
000	Oka,	1
000	FADD/MORT-1,	1
000	respectively).	1
000	(8/18,	1
000	57-264	1
000	distemper	1
000	remained	1
000	(TPM1),	1
000	(SAC6),	1
000	itself	1
000	(95,000	1
000	areas.	1
000	loci	1
000	segment-1	1
000	rdh54	1
000	immunoreactivity.	1
000	bud	1
000	(B-Cat)	1
000	(E-Cad),	1
000	dimer.	1
000	(Cx43),	1
000	(N375)	1
000	clustering,	1
000	joined	1
000	antibodies,	1
000	Myf-5,	1
000	anti-SMC	1
000	extension	1
000	(12	1
000	(DPCPX,	1
000	filaments;	1
000	versa.	1
000	NLS-less	1
000	circuit.	1
000	(DMSO)	1
000	(2.9	1
000	mating-type	1
000	L:	1
000	Finally	1
000	(17,000	1
000	UL30,	1
000	isometric	1
000	myosins	1
000	insertion/deletion	1
000	(from	1
000	(alpha-SM	1
000	Accordingly,	1
000	length	2
000	FAF,	2
000	wet	2
000	microfilaments,	2
000	(E-cad),	2
000	motility:	2
000	(plakoglobin)	2
000	loci.	2
000	polypeptides.	2
000	released	2
000	subunits,	2
000	(Mr	3
000	segments	4
000	Moreover,	5
000	I,	6
000	induces	8
000	while	8
000	than	33
000	or	113
000	and	1290
0010	C-gamma	1
0010	co-activator	1
0010	Semiserial	1
0010	PAC2	1
0010	copy	1
0010	Reversible	1
0010	Resonance	1
0010	nestin,	1
0010	Essential	1
0010	Opposite	1
0010	Porcine	1
0010	CREB-binding-protein,	1
0010	insensitive	1
0010	Motile	1
0010	P-cadherin	1
0010	Cytoplasmic	1
0010	cofilin-homology	1
0010	N-formyl	1
0010	Various	1
0010	Under	1
0010	extraction	1
0010	arterioles.	1
0010	precision	1
0010	linker	1
0010	(vc)	1
0010	WASP	1
0010	trailer	1
0010	beta-tubulin,	1
0010	calbindin,	1
0010	alpha-tubulin,	1
0010	Stable	1
0010	leader	1
0010	(F0)	1
0010	dose.	1
0010	versus	1
0010	Double	1
0010	Calorimetric	1
0010	(containing	1
0010	GAL80.	1
0010	patches,	1
0010	flow	1
0010	stabilizing	1
0010	screen.	1
0010	bears	1
0010	Calpain	1
0010	MHC-IIB(B2)	1
0010	Previous	1
0010	integrated	1
0010	factor*DNA	1
0010	pro-apoptotic	1
0010	affinity.	1
0010	L-plastin's	1
0010	Membranous	1
0010	(sNRP1)	1
0010	RIPc,	1
0010	pp125	1
0010	inflammatory	1
0010	primosome	1
0010	TEM	1
0010	BRSV-CAT	1
0010	reaction,	1
0010	Structural	1
0010	Further	1
0010	Tyrosine	1
0010	Two-hybrid	1
0010	Histone	1
0010	Such	1
0010	HR	1
0010	(CD44v6),	1
0010	cortexillin.	1
0010	vector	1
0010	1.	1
0010	ions,	1
0010	synergistic	1
0010	abundance	1
0010	GFP-Cdc42p	1
0010	severe	1
0010	speed	1
0010	molecule(s).	1
0010	Additional	1
0010	Stimulus-dependent	1
0010	clinicopathologic	1
0010	(Cdk2)	1
0010	Electrical	1
0010	dichroism	1
0010	creatine	1
0010	Photochemical	1
0010	pathogen	1
0010	Bifano,	1
0010	Direct	1
0010	(HSV)	1
0010	consisted	1
0010	elegans,	1
0010	(L),	1
0010	DDC1	1
0010	death-domain-containing	1
0010	dichroism,	1
0010	DBR1,	1
0010	lactic	1
0010	Fluorographic	1
0010	PS1	1
0010	feeding	1
0010	(LIMK1)	1
0010	(V)	1
0010	(N),	2
0010	Biochemical	2
0010	collagen,	2
0010	Actin-binding	2
0010	Transcriptional	2
0010	E/CDK2	2
0010	(HN)	2
0010	Insulin-like	2
0010	ends.	2
0010	(refs	2
0010	Total	2
0010	Actin	2
0010	ATPase	2
0010	Armadillo	2
0010	With	2
0010	Two	3
0010	Kinetic	3
0010	Western	3
0010	(NP),	3
0010	collagen	3
0010	dodecapeptide	3
0010	Three	3
0010	calponin,	3
0010	Immunohistochemical	3
0010	Natl.	3
0010	Specific	4
0010	While	4
0010	After	4
0010	Because	4
0010	An	4
0010	As	6
0010	R.	6
0010	Immunofluorescence	6
0010	Reduced	7
0010	Our	9
0010	This	20
0010	virus	34
0010	These	45
0010	The	200
0010	kinase	53
00110	particulate	1
00110	7	1
00110	classes	1
00110	multi-ubiquitinated	1
00110	interest	1
00110	alpha-SNAP	1
00110	polycephalum	1
00110	micronuclei	1
00110	sac6-69,	1
00110	(TESK1)	1
00110	PMS2	1
00110	Changes	1
00110	SMCs,	1
00110	SMCs	1
00110	dyes	1
00110	BrdU	1
00110	mDia	1
00110	concentration,	1
00110	sNRP1	1
00110	MAPK,	1
00110	exponential	1
00110	respectively)	1
00110	RFC5,	1
00110	iota	1
00110	33	1
00110	Cadherins	1
00110	RAD27	1
00110	wedged	1
00110	48-163	1
00110	(LIMKs)	1
00110	truncations	1
00110	(NP-1)	1
00110	(UL29),	1
00110	Platelet	1
00110	alpha-Catenin	1
00110	varicocele,	1
00110	MgCl2	1
00110	MDP2	1
00110	confluence	1
00110	2.8	1
00110	synergy	1
00110	pE3,	1
00110	S1)	1
00110	vertebrates,	1
00110	Cip1/WAF1	1
00110	16%,	1
00110	enhancement.	1
00110	missing	1
00110	adenomas	1
00110	ITP	1
00110	turn,	1
00110	digestion,	1
00110	Myo5p,	1
00110	MSH2-,	1
00110	0.1	1
00110	attachment.	1
00110	difference	1
00110	families.	1
00110	END5	1
00110	troponin-I	1
00110	switching	1
00110	presumably	1
00110	[Afree],	1
00110	therefore,	1
00110	TD77,	1
00110	TIF34:	1
00110	heart,	1
00110	man,	1
00110	beta-Catenin	1
00110	UL38	1
00110	(Po)	1
00110	(AtFim1)	1
00110	insulin	2
00110	actomyosin	2
00110	moving	2
00110	mitosis	2
00110	MLL	2
00110	(a)	2
00110	Wiskott-Aldrich	2
00110	protrusions	2
00110	requiring	2
00110	nucleosomes	2
00110	donor	2
00110	Ki-67	2
00110	68	2
00110	Birch	2
00110	stress,	2
00110	Sec1	2
00110	cytosolic	2
00110	AF-6	2
00110	RAD50,	2
00110	acting	2
00110	replication,	2
00110	sodium	2
00110	possibly	2
00110	actively	2
00110	BACKGROUND:	2
00110	L,	2
00110	CD26	2
00110	alterations	3
00110	There	3
00110	cDNA	3
00110	genome	3
00110	ActA	4
00110	Neuropilin-1	4
00110	S	4
00110	(HSV-1)	4
00110	turn	4
00110	platelets	5
00110	RAD9,	5
00110	It	5
00110	Aip1p	5
00110	state	5
00110	kd	6
00110	rat	6
00110	thus	6
00110	specifically	7
00110	about	7
00110	CBP	9
00110	mouse	10
00110	3	14
00110	which	104
00110	more	15
00111	[MHCK]),	1
00111	linolenic	1
00111	Plant	1
00111	phosphorylation.	1
00111	Profilins	1
00111	glutamic	1
00111	Pulse-chase	1
00111	act1-159	1
00111	concentrated.	1
00111	Hence,	1
00111	"monomeric	1
00111	ERCC1,	1
00111	(5.5	1
00111	(Hyacinthaceae).	1
00111	Polyacrylamide	1
00111	renature	1
00111	dilution	1
00111	half	1
00111	(Machesky	1
00111	full-length	1
00111	MIN6,	1
00111	become	1
00111	dihydrofolate	1
00111	Between	1
00111	O6	1
00111	regulation.	1
00111	conversion,	1
00111	resting	1
00111	factor-activated	1
00111	Bistratene	1
00111	Lamb,	1
00111	(ACC),	1
00111	postnatal	1
00111	identified.	1
00111	(SDS-PAGE),	1
00111	intestine.	1
00111	Chrivia,	1
00111	140	1
00111	intensities	1
00111	Together	1
00111	medium,	1
00111	interrelated.	1
00111	ribonucleotide	1
00111	Glutathione	1
00111	glucose.	1
00111	minigenome	1
00111	(Tbeta4).	1
00111	recognizing	1
00111	3,	1
00111	DDC2	1
00111	Actin-depolymerizing	1
00111	(Kohno	1
00111	(and	1
00111	W.	1
00111	aminonucleoside	1
00111	digitorum	1
00111	similarities	1
00111	mice,	1
00111	glass	1
00111	Hausen,	1
00111	Ledebouria	1
00111	1995,	1
00111	3'	1
00111	leucine.	1
00111	acids,	1
00111	(Myh)	1
00111	min	1
00111	Increasing	1
00111	SP2.	1
00111	organ,	1
00111	(Yonezawa,	1
00111	plus	1
00111	carcinoma.	1
00111	nephropathy.	1
00111	affected.	1
00111	Vascular	1
00111	monolayer.	1
00111	Ca(2+)-binding	1
00111	cord.	1
00111	comprises	1
00111	down-regulation.	1
00111	Act88F-/+	1
00111	techniques.	1
00111	particular,	1
00111	SMCs.	1
00111	fibrillary	1
00111	hours.	1
00111	sclerosing	1
00111	sites,	1
00111	Previously,	1
00111	8-cyclopentyl-1,3	1
00111	(staining	1
00111	nucleosome,	1
00111	(but	1
00111	nephrosis.	1
00111	cardiomyocytes,	1
00111	1994.	1
00111	(-/-)	2
00111	hand,	2
00111	staining.	2
00111	antibodies.	2
00111	influences	2
00111	S.,	2
00111	Montminy,	2
00111	1991.	2
00111	Mocarski,	2
00111	Challberg,	2
00111	(N).	2
00111	synthesis.	2
00111	Further,	2
00111	stabilized	2
00111	splicing	2
00111	promoter.	2
00111	T.	2
00111	For	2
00111	Tsurumi,	2
00111	basic	2
00111	RER	2
00111	Integrin	2
00111	created	2
00111	(1991)	2
00111	All	2
00111	Recently,	3
00111	(Crute,	3
00111	Finally,	3
00111	Recently	3
00111	raised	3
00111	Fas	3
00111	method.	3
00111	P.,	3
00111	intestinal	3
00111	A.	4
00111	(1989)	4
00111	far	4
00111	From	4
00111	sequences.	5
00111	function,	5
00111	do	6
00111	shows	6
00111	h	6
00111	TNF	6
00111	METHODS:	7
00111	By	8
00111	amino	10
00111	does	10
00111	Here,	10
00111	Here	13
00111	However,	17
00111	did	17
00111	but	75
00111	In	85
010	thaliana	1
010	11-22	1
010	suppressor,	1
010	(20	1
010	(ABPs),	1
010	effect;	1
010	other:	1
010	transfer	1
010	unconventional	1
010	TRAIL	1
010	(ChIP)	1
010	antimuscle	1
010	armadillo,	1
010	(CH3	1
010	adaptors	1
010	<0.001).	1
010	BCK1-20	1
010	decreased.	1
010	product,	1
010	joining	1
010	NLS	1
010	(0.7-2	1
010	supports	1
010	[2,3].	1
010	microcalorimetry,	1
010	FADD/MORT1,	1
010	(e.g.	1
010	H2A,	1
010	recruits	1
010	unlike	1
010	Fluorescent	1
010	(delta	1
010	TRAIL,	2
010	making	2
010	(amino	2
010	Recombinant	3
010	(1	3
010	since	4
010	=	7
010	of	1463
010	including	15
01100	coexpressing	1
01100	towards	1
01100	steady-state,	1
01100	synthetic-lethal.	1
01100	discoideum	1
01100	N-RNA	1
01100	nonfocal	1
01100	tyrphostin,	1
01100	transmembrane	1
01100	CD26,	1
01100	Aprotinin	1
01100	Molecules	1
01100	N-WASP,	1
01100	behind	1
01100	(PIP2),	1
01100	erythro-9-(2-hydroxy-3-nonyl)adenine	1
01100	profilin's	1
01100	(EHNA,	1
01100	characterized,	1
01100	P-235,	1
01100	provoked	1
01100	cholangiocarcinoma	1
01100	lesions,	1
01100	immediately	1
01100	L-[ring-2,	1
01100	KCl,	1
01100	alpha-SM	1
01100	experimentally	1
01100	until	1
01100	component,	1
01100	Cof);	1
01100	paper,	1
01100	studying	1
01100	PIP(2),	1
01100	virions,	1
01100	denaturation,	1
01100	CBP),	1
01100	SNF11,	1
01100	P:	1
01100	globule,	1
01100	single-base	1
01100	Green	1
01100	draflazine	1
01100	TEC1,	1
01100	yellow	1
01100	16	1
01100	development,	2
01100	duplication	2
01100	exclusive	2
01100	curves	2
01100	crossing	2
01100	ng/ml	2
01100	sulfate-polyacrylamide	2
01100	(2)	2
01100	PDGF	2
01100	molecules:	2
01100	Interestingly,	3
01100	almost	3
01100	measuring	3
01100	bands	3
01100	intrinsic	3
01100	supporting	4
01100	upon	4
01100	abolished	5
01100	microM),	5
01100	causes	6
01100	When	7
01100	caused	7
01100	over	8
01100	where	8
01100	although	13
01100	cells,	21
01100	whereas	27
01100	using	36
01100	as	122
01100	by	233
01101	out	1
01101	p<0.	1
01101	dissociate	1
01101	accelerated	1
01101	regarding	1
01101	ovine	1
01101	260-281)	1
01101	UL52),	1
01101	just	1
01101	hardly	1
01101	TPM1,	1
01101	Notably,	1
01101	ADP	1
01101	U.	1
01101	PCNA;	1
01101	RAD24	1
01101	First,	1
01101	NHEJ	1
01101	heterogeneous	1
01101	precociously,	1
01101	RVS167,	1
01101	CD-95-induced	1
01101	saturate	1
01101	N-(1-pyrenyl)iodoacetamide,	1
01101	POL	1
01101	cofilin-dependent	1
01101	differentiation,	1
01101	Introduction	1
01101	mimics	1
01101	diffusely	1
01101	describing	1
01101	allelic	1
01101	cascade,	1
01101	20),	1
01101	mays	1
01101	Their	1
01101	U.S.A.	1
01101	restricts	1
01101	M,	1
01101	exclusively	1
01101	components,	1
01101	inositol	1
01101	(ACT1)	1
01101	FLICE.	1
01101	(81QRTSKTLKVLTPPIT95)	1
01101	reactions	1
01101	mimicked	1
01101	biphasic	1
01101	eventually	2
01101	if	2
01101	how	2
01101	(3)	2
01101	that,	2
01101	How	2
01101	mediating	2
01101	633-642	3
01101	<	3
01101	approximately	3
01101	another,	4
01101	express	4
01101	decreased	9
01101	that	357
01101	whether	9
01110	reduces	1
01110	couples	1
01110	recombination-deficient	1
01110	PPP,	1
01110	TRAF2,	1
01110	retains	1
01110	One,	1
01110	Chick	1
01110	DR3	1
01110	entered	1
01110	Calculated	1
01110	morphologic	1
01110	accumulation.	1
01110	dimer,	1
01110	cytoskeleton].	1
01110	far,	1
01110	diffusion	1
01110	why	1
01110	motility,	1
01110	rearrangement	1
01110	VRP1,	1
01110	>	1
01110	experiment,	1
01110	explains	1
01110	networks:	1
01110	relatives,	1
01110	TESK2	1
01110	phenotypically	1
01110	polycystic	1
01110	(Arm)	1
01110	nucleation,	1
01110	Confluent	1
01110	cross-link	1
01110	mg)	1
01110	restores	1
01110	XRCC5,	1
01110	became	1
01110	immunohistochemistry	1
01110	fibers,	1
01110	canine	1
01110	Frozen	1
01110	raising	2
01110	carries	2
01110	describes	2
01110	allowed	2
01110	alleles.	2
01110	intranuclear	2
01110	66	2
01110	alters	2
01110	weakens	2
01110	provides	3
01110	tandem	3
01110	Several	3
01110	near	4
01110	enhances	4
01110	-	4
01110	before	4
01110	On	4
01110	dialyzed	4
01110	molecules,	5
01110	throughout	7
01110	Using	8
01110	within	8
01110	contains	11
01110	had	13
01110	through	18
01110	during	31
01110	into	34
01110	in	740
01110	at	78
011110	sequesters	1
011110	truly	1
011110	actin/PIP2-binding	1
011110	oligomeric	1
011110	Significantly,	1
011110	Phosphoinositides	1
011110	coiled-coils,	1
011110	E-cadherin/	1
011110	homologs,	1
011110	non-conservative	1
011110	(T1/2	1
011110	sense	1
011110	to,	1
011110	(Pol)	1
011110	alpha-Skeletal	1
011110	stain	1
011110	neutralize	1
011110	HGF/SF	1
011110	humidity,	1
011110	described.	1
011110	mapping	1
011110	Pyrenyliodoacetamide	1
011110	Mitochondrial	1
011110	molecule,	1
011110	alpha-helical	1
011110	(F0;	1
011110	easily	1
011110	themselves	1
011110	inefficiently	1
011110	possesses	1
011110	experiment	1
011110	(XRCC1,	1
011110	distant	1
011110	eliminate	1
011110	alpha-cardiac	1
011110	F:	1
011110	elsewhere	1
011110	258,	1
011110	257,	1
011110	[Tobacman,	1
011110	by,	1
011110	5-10	1
011110	HMP-1,	1
011110	isolated.	1
011110	systematically	1
011110	terminal	1
011110	fragments	2
011110	maintain	2
011110	(approximately	2
011110	266,	2
011110	disrupts	3
011110	to	559
011110	Since	6
0111110	tissues,	1
0111110	Only	1
0111110	49	1
0111110	detects	1
0111110	RPE,	1
0111110	co-activators	1
0111110	size-limited	1
0111110	encompassing	1
0111110	2B,	1
0111110	nuclei,	1
0111110	exhibiting	1
0111110	(KIX)	1
0111110	BUD2,	1
0111110	described,	1
0111110	facilitating	1
0111110	[XPPPPP,	1
0111110	filament,	1
0111110	Once	1
0111110	Of	1
0111110	accompanying	1
0111110	Myo2p	1
0111110	gelation,	1
0111110	antigen-dependent	1
0111110	(16.2%),	1
0111110	lose	1
0111110	(T	1
0111110	did,	1
0111110	neuroblastoma	1
0111110	(MMR),	1
0111110	detail	1
0111110	190	1
0111110	details	1
0111110	case,	1
0111110	cerevisiae,	1
0111110	(PCNA),	1
0111110	transcript.	1
0111110	(divergent)	1
0111110	bromide,	1
0111110	reaction.	1
0111110	calcium-dependent:	1
0111110	affects	1
0111110	Integrating	1
0111110	cases,	1
0111110	locates	1
0111110	among	1
0111110	elucidated	1
0111110	(CKIs)	1
0111110	oxidized	1
0111110	acetylated;	1
0111110	cation,	1
0111110	shortens	1
0111110	armadillo.	1
0111110	Rep68	1
0111110	culture,	1
0111110	reflected	1
0111110	stability.	2
0111110	natural	2
0111110	give	2
0111110	overcomes	2
0111110	E,	2
0111110	families,	2
0111110	At	2
0111110	promotes	2
0111110	Weller,	2
0111110	investigating	2
0111110	Within	2
0111110	concerning	3
0111110	v	3
0111110	D1,	3
0111110	(UL5,	4
0111110	ventricular	4
0111110	system,	4
0111110	around	6
0111110	proteins:	6
0111110	lacking	6
0111110	like	7
0111110	expressing	8
0111110	against	9
0111110	on	111
0111110	between	59
01111110	(eIF3-p33)	1
01111110	(p21WAF1/Cip1),	1
01111110	construct,	1
01111110	surrounding	1
01111110	(VEGF(165)),	1
01111110	stabilize	1
01111110	reduce	1
01111110	donors.	1
01111110	level,	1
01111110	ORC1,	1
01111110	mutagenized	1
01111110	(RT-PCR/SBH)	1
01111110	recruited	1
01111110	contraction-induced	1
01111110	isoform,	1
01111110	IV(CD26)	1
01111110	heteromeric	1
01111110	neurite	1
01111110	triply	1
01111110	triggering	1
01111110	deltaN151)	1
01111110	tested,	1
01111110	yielded	2
01111110	reveals	2
01111110	developed	2
01111110	colon	2
01111110	glycoprotein	2
01111110	expression.	2
01111110	respectively),	2
01111110	(2	3
01111110	Like	3
01111110	share	3
01111110	reveal	3
01111110	because	3
01111110	Both	4
01111110	exhibited	4
01111110	overexpressing	4
01111110	suppresses	5
01111110	involves	5
01111110	requires	9
01111110	inhibits	10
01111110	via	10
01111110	under	12
01111110	encoding	12
01111110	containing	27
01111110	with	364
01111110	from	103
01111111	Mr).	1
01111111	DNA,	1
01111111	(N-cadherin,	1
01111111	KU70(-/-)	1
01111111	aberrant	1
01111111	mAb	1
01111111	ANP,	1
01111111	Madin-Darby	1
01111111	grown	1
01111111	terminating	1
01111111	restrictions	1
01111111	binding)	1
01111111	(encoding	1
01111111	(EMA),	1
01111111	(PFNs),	1
01111111	(desmin,	1
01111111	starting	1
01111111	(TNF-RI,	1
01111111	LF,	1
01111111	(68,000	1
01111111	artery	1
01111111	ligand-binding	1
01111111	co-operativity	1
01111111	transcriptase	1
01111111	stripping	1
01111111	LNYV	1
01111111	(E-cadherin,	2
01111111	(M),	2
01111111	epithelium.	2
01111111	selection	2
01111111	cadherin,	2
01111111	antagonist	3
01111111	gave	3
01111111	Furthermore,	3
01111111	Mr),	3
01111111	extensive	4
01111111	included	4
01111111	Although	10
01111111	for	238
01111111	Thus,	12
10000	cAMP-responsive	1
10000	sperm-specific	1
10000	cation	1
10000	proliferation	1
10000	flow,	1
10000	caspase	1
10000	phosphotyrosine-containing	1
10000	Xenopus	1
10000	verprolin-cofilin-acidic	1
10000	Acidic	1
10000	complex-dependent	1
10000	E-cadherin-associated	1
10000	headpiece	1
10000	broken	1
10000	p16(INK4A)	1
10000	SUI1	1
10000	Morales	1
10000	urethral	1
10000	actin-sequestering	1
10000	myotube	1
10000	15-kDa	1
10000	His	1
10000	cofilin-binding	1
10000	E1A	1
10000	G2	1
10000	open	1
10000	(AJ)	1
10000	cadherin-associated	1
10000	syndrome	1
10000	18S	1
10000	120	1
10000	Signaling	1
10000	>2	1
10000	eosin	1
10000	ribbon-to-helix	1
10000	speeds	1
10000	stimulus-to-His	1
10000	domain-associated	1
10000	calponin-homology	1
10000	644-aa	1
10000	metabolically	1
10000	u.v.	1
10000	CAT	1
10000	actin-monomer-binding	1
10000	avidin-biotin	1
10000	degradation.	1
10000	Fas-associated	1
10000	"fetal"	1
10000	Pkc1p	1
10000	conservative	1
10000	remaining	1
10000	twinstar	1
10000	chromosome.	1
10000	unmodified	1
10000	occulta	1
10000	(the	1
10000	(mean	1
10000	alpha-Smooth	1
10000	bipolar	1
10000	anticancer	1
10000	Modifying	1
10000	213-218;	1
10000	poly-(L)-proline-binding	1
10000	faster	1
10000	protein-tagged	1
10000	third	1
10000	[1].	1
10000	Ras-Raf-mitogen-activated	1
10000	surfaces.	1
10000	SPA2,	1
10000	subdomain	1
10000	contacts.	1
10000	host-parasite	1
10000	phenotypic	1
10000	NH(2)-terminal	1
10000	immunological	1
10000	(cytoplasmic)	1
10000	(4	1
10000	subfragment	1
10000	dsRNA-activated	1
10000	unidentified	1
10000	5-10%	1
10000	actin-crosslinking	1
10000	coiled-coil	1
10000	glutamate-rich	1
10000	anterior	1
10000	filament-bundling	1
10000	HHR23A	1
10000	division	1
10000	individual	1
10000	phosphotyrosyl-containing	1
10000	FH	1
10000	(C)	1
10000	c-jun	1
10000	talin-positive	1
10000	HCM.	1
10000	sieve-tube	1
10000	(76.4%)	1
10000	vitamin	1
10000	'nuclear	1
10000	Apc(Min/+)	1
10000	110,000-dalton	1
10000	Neuropilin	1
10000	thickened,	1
10000	supernatant.	1
10000	ubiquitin-dependent	1
10000	margin	1
10000	pathologic	1
10000	Rap1A	1
10000	sole	1
10000	hepatic	1
10000	6.	1
10000	apoptosis-initiating	1
10000	ODN.	1
10000	gestational	1
10000	Rad51/Rad52	1
10000	(43,000	1
10000	(nucleotide	1
10000	topographical	1
10000	was,	1
10000	"death	1
10000	110	1
10000	hypothetical	1
10000	RAD5	1
10000	lumbar	1
10000	RT1	1
10000	unaltered	1
10000	collagenase	1
10000	immunoadsorption	1
10000	actin-and	1
10000	endocardial	1
10000	flanking	1
10000	physiochemical	1
10000	HMR-1	1
10000	single-domain	1
10000	heptapeptide	1
10000	head,	1
10000	Rb	1
10000	galactose	1
10000	applied	1
10000	c-Raf-1-BxB-ER	1
10000	type-specific	1
10000	RAS	1
10000	brightly	1
10000	spliceosomal	1
10000	flight	1
10000	phosphatase	1
10000	chromatography.	1
10000	mitochondrial	1
10000	origin-binding	1
10000	alkylating	1
10000	actin-severing	1
10000	tetracycline-repressible	1
10000	substrates,	1
10000	(SH)	2
10000	actin-related	2
10000	H,	2
10000	haemagglutinin	2
10000	prereplicative	2
10000	residue	2
10000	actin-bundling	2
10000	Smooth	2
10000	E-cdk2	2
10000	multifunctional	2
10000	predominant	2
10000	abundant	2
10000	cytoskeleton-associated	2
10000	S-100	2
10000	87K	2
10000	Mammalian	2
10000	transient	2
10000	Olivo,	2
10000	adapter	2
10000	ATP-sensitive	2
10000	crystal	2
10000	Arp2	2
10000	V	2
10000	mutS	2
10000	actin-mediated	2
10000	kDa)	2
10000	activating	2
10000	unassembled	2
10000	mitogen-activated	2
10000	SIR	2
10000	trans-acting	2
10000	postsynaptic	2
10000	spatial	2
10000	actin-regulatory	2
10000	fluorescently	3
10000	capping	3
10000	domain-containing	3
10000	adaptor	3
10000	spectrin	3
10000	acidic	3
10000	heterologous	3
10000	prognostic	3
10000	eIF3	3
10000	neuromuscular	3
10000	lipid	4
10000	CREB-binding	4
10000	active	4
10000	DNA-binding	4
10000	crosslinking	4
10000	blot	4
10000	myofibrillar	4
10000	mixed	4
10000	muscle-specific	4
10000	endogenous	5
10000	signalling	5
10000	immunohistochemical	5
10000	Rho	5
10000	head	6
10000	inhibitory	6
10000	proline-rich	6
10000	actin-associated	7
10000	monomer-binding	7
10000	core	7
10000	sequestering	7
10000	actin-depolymerizing	7
10000	regulatory	8
10000	novel	8
10000	structural	9
10000	functional	11
10000	cytoplasmic	12
10000	contractile	12
10000	total	12
10000	N-terminal	13
10000	large	13
10000	UL8	14
10000	alpha-smooth	14
10000	UL5,	18
10000	smooth	21
10000	cytoskeletal	24
10000	nucleocapsid	25
10000	skeletal	25
10000	actin-binding	80
10001	(induced	1
10001	wall.	1
10001	0.05).	1
10001	ultrastructural	1
10001	21,000	1
10001	BRSV	1
10001	solution,	1
10001	precise	1
10001	inaccessible	1
10001	tested.	1
10001	actin/poly-proline	1
10001	substantial	1
10001	valine	1
10001	alpha-catenin-binding	1
10001	collagens.	1
10001	supramolecular	1
10001	frequent	1
10001	NSCLC,	1
10001	perfringens	1
10001	90-kDa	1
10001	BIR.	1
10001	somite.	1
10001	cytoplasm.	1
10001	Pervanadate	1
10001	RAD51-interacting	1
10001	p21WAF1	1
10001	deaminase,	1
10001	subjects	1
10001	urethra	1
10001	part,	1
10001	cooperative	1
10001	exchanges.	1
10001	phosphoinositide-signaling	1
10001	deaminase-binding	1
10001	lesser	1
10001	plants,	1
10001	profilins;	1
10001	microfilament-rich	1
10001	Triton	1
10001	phenylalanine	1
10001	Sequence	1
10001	CAN1	1
10001	subcellular	1
10001	serine/threonine	1
10001	contact,	1
10001	'barbed'	1
10001	Chemical	1
10001	NH2	1
10001	1-12.	1
10001	translational	1
10001	130-kDa	1
10001	distinct,	1
10001	old.	1
10001	MHC-IIB(DeltaB2)	1
10001	extra	1
10001	(0.25	1
10001	information	1
10001	crystallographic	1
10001	COOH-terminal	1
10001	yeast-based	1
10001	actin-polymerization	1
10001	mobility	1
10001	chromatin-containing	1
10001	changed	1
10001	age.	1
10001	implications.	1
10001	x-ray	1
10001	discrete	1
10001	receptor.	1
10001	significant.	1
10001	mononucleated	1
10001	termed	1
10001	calcium.	1
10001	cartilage	1
10001	physiologically	1
10001	internalization	1
10001	mutation,	1
10001	kinase),	1
10001	p21.	1
10001	thermal	1
10001	splicing;	1
10001	calponin.	1
10001	DSB	1
10001	fetal	1
10001	ribbons.	1
10001	TNF-dependent	1
10001	leucine	1
10001	mechanoreceptive	1
10001	constitutive	1
10001	Rinderpest	1
10001	(JNK/SAPK)	1
10001	PPH,	1
10001	baculovirus	1
10001	myofibrillar-enriched	1
10001	1-adrenergic	1
10001	brain.	1
10001	Ca(2+)-	1
10001	actin-activated	1
10001	lethality	1
10001	High	1
10001	non-cortical	1
10001	profilin-like	1
10001	cell.	1
10001	beta-catenin*T-cell	1
10001	poly(L-proline)-binding	1
10001	morphology.	1
10001	marked	1
10001	seconds,	1
10001	species.	1
10001	fiber	1
10001	decrease,	1
10001	random.	1
10001	0.7-4	1
10001	lyophilized	1
10001	fundamental	1
10001	bundles,	1
10001	obvious	1
10001	60-69	1
10001	dramatic	1
10001	cofilin-associated	1
10001	240-kd	1
10001	posttranscriptional	1
10001	fibronectin-coated	1
10001	polarised	1
10001	(core)	1
10001	myosin-I.	1
10001	intricate	1
10001	linkage	1
10001	exocytosis.	1
10001	MTLn3	1
10001	1980.	1
10001	developmental	1
10001	syntrophin-binding	1
10001	reserve	1
10001	light-evoked	1
10001	p27kip1.	1
10001	fibres	1
10001	54	1
10001	structures.	1
10001	inner	1
10001	dsRNA	1
10001	MNNG.	1
10001	DEAD	1
10001	agents,	1
10001	HT29	1
10001	cholesterol	1
10001	number.	1
10001	fimbrin/plastin	1
10001	trend	1
10001	confluent	1
10001	CO	1
10001	chemical	1
10001	NAB1,	1
10001	beta-hairpin	1
10001	catalytic	1
10001	RBL	1
10001	circumstances	1
10001	stimulus-response	1
10001	XIII	1
10001	deaminase),	1
10001	GAF/PAS	1
10001	nonerythroid	1
10001	molten	1
10001	overlapping	1
10001	p27(Kip1).	1
10001	27	1
10001	cytokinesis.	2
10001	cognate	2
10001	Protein	2
10001	template	2
10001	COOH	2
10001	repeats,	2
10001	better	2
10001	fully	2
10001	profilin-induced	2
10001	(0.1	2
10001	hamster	2
10001	lateral	2
10001	265-kDa	2
10001	LIM	2
10001	verprolin-homology	2
10001	limited	2
10001	simultaneous	2
10001	moderate	2
10001	activated	2
10001	basolateral	2
10001	cell,	2
10001	culture.	2
10001	CONCLUSIONS:	2
10001	mutually	2
10001	SDS-PAGE	2
10001	deaminase.	2
10001	migrating	2
10001	plants	2
10001	simian	3
10001	mM	3
10001	phospholipase	3
10001	bundles.	3
10001	potent	3
10001	circular	3
10001	medial	3
10001	complementary	3
10001	reverse	3
10001	mature	3
10001	lower	3
10001	host	3
10001	recruiting	3
10001	dynamic	3
10001	simple	3
10001	slow	3
10001	stomatitis	3
10001	early	3
10001	adhesive	4
10001	catenin	4
10001	key	4
10001	LIM-kinase	4
10001	hair	4
10001	synthetic	4
10001	strong	4
10001	30	4
10001	degrees	5
10001	linking	5
10001	direct	5
10001	formation.	5
10001	amino-terminal	5
10001	IV	5
10001	physiological	5
10001	vitro.	5
10001	vivo.	7
10001	central	7
10001	new	8
10001	vaccinia	8
10001	tyrosine	9
10001	low	10
10001	barbed	11
10001	cellular	12
10001	intracellular	13
10001	signaling	15
10001	simplex	16
10001	well	18
10001	such	24
10001	cyclin-dependent	28
10001	high	26
10010	50%	1
10010	them,	1
10010	bearing	1
10010	quantify	1
10010	clathrin	1
10010	activation-induced	1
10010	C374S	1
10010	poor	1
10010	3-D	1
10010	rad50	1
10010	qualitative	1
10010	(NSCLC)	1
10010	eggs	1
10010	library	1
10010	microvilli,	1
10010	activity-dependent	1
10010	mild	1
10010	coiledcoil	1
10010	myotubules	1
10010	keratin	1
10010	SVT	1
10010	VSMC	1
10010	gut	1
10010	Cdc42-induced	1
10010	layer,	1
10010	nucleates	1
10010	msh6	1
10010	spliceosome	1
10010	catalyzing	1
10010	forskolin,	1
10010	FADD-DN's	1
10010	RAD1	1
10010	NMR	1
10010	competitive	1
10010	Live	1
10010	accumulating	1
10010	salt-induced	1
10010	12P-CRE	1
10010	smooth-sided	1
10010	transcription,	1
10010	integrator	1
10010	isotopic	1
10010	electrophoresis,	1
10010	facilitates	1
10010	cotranslational	1
10010	detectable	1
10010	Developmental	1
10010	Germline	1
10010	DFG16,	1
10010	effective	1
10010	PI	2
10010	ordered	2
10010	late	2
10010	actin-containing	2
10010	actin-filament	2
10010	barbed-end	2
10010	typical	2
10010	mechanical	2
10010	actin;	2
10010	paxillin	2
10010	spontaneous	2
10010	hypertrophic	2
10010	apoptosis-related	2
10010	morphological	2
10010	cerebellar	2
10010	myofibril	2
10010	growing	2
10010	axonal	3
10010	primer	3
10010	them	3
10010	myogenin	3
10010	cysteine	4
10010	point	5
10010	fractional	6
10010	RNA	7
10010	tropomyosin	8
10010	ATP	8
10010	actin-based	11
10010	actin	555
10011	deep	1
10011	beta-cell	1
10011	programmed	1
10011	mispair	1
10011	(MAPK)/extracellular	1
10011	unstimulated	1
10011	conduction	1
10011	TNM	1
10011	BALB/c-3T3	1
10011	polypeptides;	1
10011	cell-substratum	1
10011	recognition.	1
10011	cystic	1
10011	angiogenesis	1
10011	B1,	1
10011	actin-saturated	1
10011	actin-nucleotide	1
10011	overlapping,	1
10011	DR4	1
10011	associations:	1
10011	dense	1
10011	property	1
10011	inactivating	1
10011	(GLA)	1
10011	gephyrin,	1
10011	effect,	1
10011	crossbridge	1
10011	truncus.	1
10011	Adherens	1
10011	homogenous	1
10011	kDa.	1
10011	way.	1
10011	complexes,	1
10011	cell-to-cell	1
10011	(molecular	1
10011	exceeding	1
10011	location	1
10011	aspects	1
10011	G,	1
10011	uterine	1
10011	ions	1
10011	X-ray	1
10011	temperature	1
10011	2:	1
10011	mimosine-treated	1
10011	HS578t	1
10011	illegitimate	1
10011	(aa)	1
10011	E-cdk2,	1
10011	deduced	1
10011	immunoglobulin	1
10011	hyperproliferative	1
10011	principal	1
10011	Src	1
10011	(EDL)	1
10011	Four	1
10011	microtubule	2
10011	ectopic	2
10011	recombinational	2
10011	PRRs,	2
10011	actin-dependent	2
10011	receptor-mediated	2
10011	bladder	2
10011	intercellular	2
10011	gizzard	2
10011	Schizosaccharomyces	2
10011	SNF-SWI	2
10011	wound	2
10011	pigment	2
10011	tumour	2
10011	parental	2
10011	cadherin-catenin	3
10011	RAD1,	3
10011	silencing	3
10011	initial	3
10011	respiratory	3
10011	apoptotic	3
10011	endocytic	3
10011	cytoplasm,	3
10011	strand	3
10011	hybrid	3
10011	H.	3
10011	transcript	3
10011	Listeria	3
10011	ovarian	3
10011	differential	4
10011	high-affinity	4
10011	neonatal	4
10011	break	4
10011	19	4
10011	A,	4
10011	efficient	4
10011	microvillus	4
10011	fibronectin	4
10011	genetic	5
10011	molar	5
10011	HSV	5
10011	apical	5
10011	adherens	5
10011	G1	5
10011	checkpoint	6
10011	any	7
10011	phosphatidylinositol	7
10011	significant	7
10011	physical	7
10011	least	8
10011	S.	9
10011	mismatch	10
10011	CREB	10
10011	five	10
10011	following	10
10011	cell-cell	11
10011	plasma	11
10011	two-hybrid	11
10011	same	11
10011	molecular	13
10011	recombinant	18
10011	focal	18
10011	Saccharomyces	18
10011	beta	22
10011	nucleotide	24
10011	phosphoprotein	29
10011	growth	30
10011	DNA	52
10011	cell	96
10011	histone	57
10100	64%	1
10100	exceptionally	1
10100	initiates	1
10100	Quantitative	1
10100	dramatically	1
10100	advanced	1
10100	high-pressure	1
10100	trophic-factor-mediated	1
10100	hypertrophy.	1
10100	semaphorins,	1
10100	Rod	1
10100	3-OH	1
10100	PF4-dependent	1
10100	liposomes.	1
10100	Sequences	1
10100	lysine	1
10100	'+').	1
10100	prevents	1
10100	ERK2,	1
10100	maintenance.	1
10100	pGEM-based	1
10100	Conversely,	1
10100	rheological,	1
10100	MluI	1
10100	immunoblotting;	1
10100	SCE	1
10100	mononucleotide	1
10100	adults.	1
10100	directs	1
10100	duplex	1
10100	VEGF165	1
10100	(4)	1
10100	DNA-PK.	1
10100	lytic	1
10100	biologically	1
10100	evolution.	1
10100	synaptojanin	1
10100	[Molecular	1
10100	intravenous	1
10100	proper	1
10100	neighboring	1
10100	undergo	1
10100	Rho-induced	1
10100	Rb,	1
10100	synapse	1
10100	HRG	1
10100	PIP2.	1
10100	S.K.,	1
10100	germ-line	1
10100	bombesin-stimulated	1
10100	phosphorylating	1
10100	electrophoretically	1
10100	profilin-agarose.	1
10100	memberanous	1
10100	optimal	1
10100	disparate	1
10100	ADF/cofilin,	1
10100	tritium	1
10100	local	1
10100	delicate	1
10100	beta-catenin),	1
10100	B2	1
10100	great	1
10100	sectioned	1
10100	high-molecular-weight	1
10100	ACh.	1
10100	ORC3	1
10100	fluid-phase	1
10100	starvation-induced	1
10100	furrow	1
10100	M1	1
10100	trypsin	1
10100	chemoattractant	2
10100	Dictyostelium.	2
10100	calpain.	2
10100	CBP.	2
10100	straight	2
10100	Selective	2
10100	situ	2
10100	adolescent	2
10100	preliminary	2
10100	(i)	2
10100	short	2
10100	pCa	2
10100	utrophin.	2
10100	varying	2
10100	BUD3,	2
10100	ruffling	2
10100	Molecular	3
10100	pyrene-labeled	3
10100	membranous	4
10100	LIMK2	4
10100	additional	4
10100	kDa),	5
10100	repeat	5
10100	various	7
10100	free	11
10100	the	1424
10100	their	34
10101	postulated,	1
10101	Syndrome	1
10101	35%	1
10101	polyphosphoinositides,	1
10101	PCR	1
10101	pairwise	1
10101	EGTA-containing	1
10101	fibroblasts:	1
10101	beta-catenin/plakoglobin.	1
10101	45	1
10101	Another	1
10101	E-cadherin/plakoglobin	1
10101	activated,	1
10101	ROM2,	1
10101	entering	1
10101	Caspase-8.	1
10101	motile,	1
10101	dialysis:	1
10101	IgG	1
10101	introducing	1
10101	baculovirus.	1
10101	H119E	1
10101	NCF2	1
10101	IC50	1
10101	GAL4-AH-nucleosome	1
10101	stretched	1
10101	ligand	1
10101	immunoreactive	1
10101	native,	1
10101	54,	1
10101	HER-2	1
10101	Fujita,	1
10101	far-u.v.	1
10101	23%	1
10101	GIC2	1
10101	disclosed	1
10101	micromolar	1
10101	mutagenesis.	1
10101	clusterin	1
10101	vestibular	1
10101	Fyn-dependent	1
10101	PDGF-AB,	1
10101	6-3H]phenylalanine	1
10101	functionally,	1
10101	LoVo	1
10101	FADD's	1
10101	continuous	1
10101	confocal	1
10101	clenbuterol.	1
10101	kinase-inducible	1
10101	mdx	1
10101	myofibrils,	1
10101	inappropriate	1
10101	PU.1,	1
10101	25-50%,	1
10101	viscosity,	1
10101	Increased	1
10101	multinucleated	1
10101	LIM-kinase.	1
10101	granule	1
10101	doubly	1
10101	Clostridium	1
10101	E1A-associated	1
10101	existing	1
10101	polypeptide-calmodulin	1
10101	oligoproline-rich	1
10101	quick	1
10101	serum-free	1
10101	imaging	1
10101	alternative	1
10101	proteolytic	1
10101	MV,	1
10101	WHI3,	1
10101	(CC).	1
10101	myosin's	1
10101	(PIP2)	1
10101	(gp130)	1
10101	glutamate	1
10101	ca.	1
10101	verprolin,	2
10101	31	2
10101	profilins,	2
10101	site-directed	2
10101	native	2
10101	VEGF	2
10101	latrunculin	2
10101	37	2
10101	tryptic	2
10101	thrombin	2
10101	preventing	2
10101	increasing	2
10101	quantitative	2
10101	actin:	2
10101	mutations,	2
10101	too	2
10101	methyltransferase	2
10101	Tax	3
10101	NH2-terminal	3
10101	otherwise	3
10101	cytochalasin	3
10101	vesicular	3
10101	EGF	3
10101	(a	4
10101	One	4
10101	microspike	4
10101	porcine	5
10101	higher	5
10101	MSH2,	6
10101	yet	6
10101	very	6
10101	50	7
10101	fluorescence	13
10101	adenosine	21
10101	its	52
10101	a	368
101100	Arg	1
101100	casein,	1
101100	investigated.	1
101100	MPK1	1
101100	SH3-binding	1
101100	EGF-stimulated	1
101100	rods	1
101100	slot-blot	1
101100	Mercenaria	1
101100	phagocyte	1
101100	non-equilibrium	1
101100	metabolic	1
101100	giving	1
101100	rounded	1
101100	Rho-ROCK	1
101100	Complete	1
101100	Hirano	1
101100	profilin-specific	1
101100	coefficients,	1
101100	conflicting	1
101100	implicating	1
101100	submembranous	1
101100	alpha-catenin;	1
101100	conjugated	1
101100	ecto-5'-nucleotidase	1
101100	vitro:	1
101100	pH-sensitive	1
101100	histological	1
101100	opposite	1
101100	CIN1,	1
101100	NCI	1
101100	flocculant	1
101100	external	1
101100	G-buffer	1
101100	TRAF	1
101100	disorganized	1
101100	wingless	1
101100	glucocorticoid	1
101100	anomalous	1
101100	northern	1
101100	gallbladder	1
101100	experimental	1
101100	newly	1
101100	'consensus'	1
101100	granular	1
101100	isolate	1
101100	interferon-induced,	1
101100	DMSO,	1
101100	infusions	1
101100	Northern	1
101100	minigenome,	1
101100	regional	1
101100	verprolin/cofilin-like	1
101100	tarsal	1
101100	validating	1
101100	Myc	1
101100	110-kD	1
101100	low-M(r)	1
101100	hippocampus,	1
101100	Factor-XIIIa,	1
101100	rigid	1
101100	Arg95/Arg372	1
101100	HSV-1	1
101100	anti-Aip1	1
101100	definitive	1
101100	unstable	1
101100	21-kDa	1
101100	identifies	1
101100	medullary	1
101100	RAD57.	1
101100	virus-coded	1
101100	msh6-F337A	1
101100	stimulus-dependent	1
101100	semi-conserved	1
101100	killing	2
101100	restriction	2
101100	steady-state	2
101100	antisense	2
101100	nine	2
101100	reorganizing	2
101100	35	2
101100	200	2
101100	specialized	2
101100	Torpedo	2
101100	generate	2
101100	replacement	2
101100	ubiquitous	2
101100	44%	2
101100	utrophin	2
101100	cross-links	2
101100	certain	3
101100	modified	3
101100	EGFR	3
101100	ternary	3
101100	RVS167	3
101100	whose	3
101100	place	3
101100	net	3
101100	alpha-skeletal	3
101100	c-Jun	4
101100	unpolymerized	4
101100	altered	4
101100	common	4
101100	relatively	4
101100	indirect	4
101100	60	4
101100	another	4
101100	profilin:	4
101100	conventional	4
101100	remodeling	4
101100	dipeptidyl	5
101100	gel	5
101100	developing	5
101100	vivo,	6
101100	many	6
101100	little	6
101100	our	7
101100	filamentous	7
101100	fluorescent	7
101100	tumor	10
101100	cortical	11
101100	Arp2/3	11
101100	rabbit	12
101100	specific	17
101100	all	21
101100	different	23
101100	an	108
101101	beta9	1
101101	co-stimulatory	1
101101	PIP2-binding	1
101101	135),	1
101101	depolymerizes	1
101101	organelle-rich	1
101101	dividing	1
101101	Aequipecten	1
101101	directing	1
101101	present.	1
101101	5'-triphosphate.	1
101101	METHODS	1
101101	chromosome;	1
101101	(SM)	1
101101	stretch,	1
101101	87-90	1
101101	few	1
101101	bending	1
101101	agent	1
101101	correct	1
101101	congenitally	1
101101	anti-SM2	1
101101	WH2	1
101101	immunoperoxidase	1
101101	actinin,	1
101101	dimeric	1
101101	Archaeal	1
101101	value.	1
101101	MyoD1,	1
101101	stimulating	1
101101	dicot	1
101101	E-CD;	1
101101	(PIMT),	1
101101	polygonal	1
101101	polypeptide,	1
101101	BACKGROUND	1
101101	(IHC)	1
101101	Abnormal	1
101101	especially	1
101101	components:	1
101101	junction.	1
101101	preselected	1
101101	Monoclonal	1
101101	tetanic	1
101101	fraction,	1
101101	depolarized	1
101101	3-kinase	1
101101	stage.	1
101101	enterocytes,	1
101101	21	1
101101	Dynamic	1
101101	HRR25	1
101101	polymerizable	1
101101	branched	1
101101	applicability,	1
101101	alpha-spectrin	1
101101	1/10,	1
101101	cys-374-labeled	1
101101	crosslink	1
101101	-transformed	1
101101	(beta,	1
101101	entangled	1
101101	laevis	1
101101	(subfragment	1
101101	neuraminidase	1
101101	(M;	1
101101	stacked	1
101101	alpha-smooth-muscle	1
101101	CREBbinding	1
101101	TnI.	1
101101	calcium-binding	1
101101	22)	1
101101	bacterial	1
101101	ligands:	1
101101	intermembrane	1
101101	helicase-like	1
101101	muscle-type	1
101101	classify	1
101101	lysed	1
101101	nonpolymerized	1
101101	interstitial	1
101101	profilin-promoted	1
101101	3T3	1
101101	digesting	1
101101	12-week-old	1
101101	269,	1
101101	alpha-Sm	1
101101	rRNA,	1
101101	FH1	1
101101	nonmuscle-type	1
101101	collagens,	1
101101	Seventeen	1
101101	alpha-helical/beta-sheet	1
101101	mRNA:18S	2
101101	experiments,	2
101101	MATERIALS	2
101101	talin-like	2
101101	pyrenyl-labeled	2
101101	A.,	2
101101	SM	2
101101	carp	2
101101	nonfilamentous	2
101101	fast	2
101101	implicate	2
101101	polyclonal	2
101101	P.	2
101101	non-muscle	2
101101	p21/waf1	2
101101	tumors,	3
101101	(L)	3
101101	Lehman,	3
101101	G	3
101101	nonmuscle	3
101101	striated	3
101101	unknown	3
101101	amoeba	3
101101	daltons),	3
101101	genomic	4
101101	sarcomeric	4
101101	segment	5
101101	binding,	5
101101	and/or	6
101101	bundle	6
101101	soluble	7
101101	much	7
101101	labeled	7
101101	monomeric	13
101101	alpha	15
101101	muscle	66
101101	proteins,	27
101110	chemotactic	1
101110	myofibrillogenesis	1
101110	moderately-well	1
101110	esophageal	1
101110	M21	1
101110	avian	1
101110	anti-gelsolin	1
101110	untransfected	1
101110	78	1
101110	crude	1
101110	(eIF3)	1
101110	hosts	1
101110	RHO2,	1
101110	12-15-kD	1
101110	clinicopathological	1
101110	cadherin;	1
101110	65-kD	1
101110	cloning,	1
101110	conventionally	1
101110	SV40-infected	1
101110	temperature-sensitive	1
101110	BT549	1
101110	HTLV-1-infected	1
101110	rhp51	1
101110	adenoid	1
101110	127	1
101110	exogenous	1
101110	rad52-20	1
101110	labial	1
101110	ACC,	1
101110	Cys	1
101110	airway	1
101110	classic	1
101110	mast	1
101110	15-fold	1
101110	substoichiometric	1
101110	solution	1
101110	SAC6	1
101110	hypertrophied	1
101110	75-100	1
101110	virus-encoded	1
101110	4166-4170;	1
101110	transendothelial	1
101110	Sla2p's	1
101110	diseased	1
101110	oncostatin	1
101110	Apc(+/+)	1
101110	(deltaN90)	1
101110	ligated	1
101110	generative	1
101110	Cardiac	1
101110	axial	1
101110	monocot	1
101110	presumptive	1
101110	peri-junctional	1
101110	waltzing	1
101110	pure	1
101110	ribonuclease	1
101110	cytokinesis	1
101110	radiolabelling	1
101110	diaphanous,	1
101110	segmentation,	1
101110	sgs1	1
101110	clusters;	1
101110	nonfrail	1
101110	past	1
101110	testicular	1
101110	HHUA	1
101110	candidate	1
101110	actin:thymosin	1
101110	20%	1
101110	52%,	1
101110	mesenchymal	1
101110	52/68	1
101110	nodes	1
101110	neutrophil-like	1
101110	glomerular	1
101110	intact	1
101110	repression,	1
101110	beta1D	1
101110	localize	1
101110	neural	1
101110	1.1-1.5	1
101110	essentially	1
101110	profound	1
101110	anti-functional	1
101110	Equine	1
101110	ADE2	1
101110	G(1)-S	1
101110	aromatic	1
101110	macrophage	1
101110	amphioxus	1
101110	Hodgkin	1
101110	acetylase,	1
101110	49%	1
101110	skeletal,	1
101110	Japan	1
101110	rap1	1
101110	heterodimeric	1
101110	metazoan	1
101110	NM-type	1
101110	repressed	1
101110	3.6	1
101110	degenerating	1
101110	rad5	1
101110	0.2-8.5	1
101110	cell-free	1
101110	virus-infected	1
101110	telomeres	1
101110	TNFR1-linked	1
101110	nondeleted	1
101110	metaphase	1
101110	immunoblots.	1
101110	TXB2	1
101110	epithelioid	1
101110	tube	1
101110	extract	2
101110	HeLa	2
101110	eukaryotic	2
101110	brain,	2
101110	mutated	2
101110	transformed	2
101110	IMR-90	2
101110	heated	2
101110	fixed	2
101110	utrophin,	2
101110	C2	2
101110	S.cerevisiae	2
101110	internal	2
101110	(1)	2
101110	pancreatic	2
101110	rhodamine-labeled	2
101110	Yeast	2
101110	(birch)	2
101110	old	2
101110	constitutively	2
101110	basal	2
101110	fission	2
101110	non-small	2
101110	villin,	2
101110	translated	2
101110	ionic	2
101110	carcinomas,	2
101110	T7	2
101110	metastatic	2
101110	awake	2
101110	Ser-3	2
101110	gastric	2
101110	complete	2
101110	calf	3
101110	solid	3
101110	modulating	3
101110	spleen	3
101110	chick	3
101110	Caco-2	3
101110	globular	3
101110	phosphorylate	3
101110	guinea	3
101110	parallel	3
101110	six	3
101110	muscarinic	3
101110	example,	3
101110	polymerized	3
101110	enhancing	3
101110	pig	3
101110	detailed	3
101110	concomitant	3
101110	motile	3
101110	20	3
101110	63	3
101110	differentiated	4
101110	vitro,	4
101110	diffuse	4
101110	phosphorylated	4
101110	regulating	4
101110	Tetrahymena	4
101110	young	4
101110	1:1	4
101110	cancer	4
101110	kidney	4
101110	Dictyostelium	4
101110	heat	5
101110	truncated	5
101110	single	5
101110	budding	5
101110	bovine	6
101110	monoclonal	6
101110	acetylated	6
101110	FADD,	6
101110	transcriptional	6
101110	10	6
101110	proliferating	7
101110	Drosophila	8
101110	rapid	8
101110	living	8
101110	birch	9
101110	animal	9
101110	wild-type	9
101110	putative	9
101110	pollen	9
101110	chicken	9
101110	infected	10
101110	T	10
101110	brain	10
101110	vivo	11
101110	platelet	12
101110	plant	13
101110	mammalian	13
101110	cardiac	14
101110	viral	14
101110	purified	14
101110	either	16
101110	RAD51,	19
101110	normal	19
101110	vitro	20
101110	three	26
101110	Acanthamoeba	30
101110	both	55
101110	human	49
101110	yeast	54
101111	neurons	1
101111	rhp54+	1
101111	islet-type	1
101111	shear,	1
101111	Recent	1
101111	acetylation,	1
101111	leukocytes].	1
101111	20K	1
101111	hepatocellular	1
101111	p53-mediated	1
101111	45-kDa	1
101111	superoxide	1
101111	accelerate	1
101111	extrahepatic	1
101111	clinical	1
101111	growing,	1
101111	Sepharose	1
101111	Myogenin	1
101111	non-oncogenic	1
101111	sections,	1
101111	Brenner,	1
101111	cervical	1
101111	considerable	1
101111	Smeal,	1
101111	MORT1	1
101111	alternate	1
101111	islet	1
101111	A23R,	1
101111	rad18	1
101111	Sakai,	1
101111	calcium-dependent	1
101111	PD	1
101111	platelet-poor	1
101111	preexisting	1
101111	Paraffin-embedded	1
101111	ribosomal	1
101111	E24	1
101111	CRE-dependent	1
101111	talin-rich	1
101111	assay,	1
101111	germ	1
101111	diploid	1
101111	talin-containing	1
101111	Tonouchi,	1
101111	NK	1
101111	U937	1
101111	CAP2)	1
101111	CD44v5,	1
101111	"dashes"	1
101111	RSV	1
101111	RAD53	1
101111	non-adherent	1
101111	methyltransferase-deficient	1
101111	thousands)	1
101111	Ca2+	1
101111	flattened	1
101111	77	1
101111	biopsy	1
101111	mesangial	1
101111	actin-anchoring	1
101111	Wistar-Furth	1
101111	SV40	1
101111	cap-	1
101111	protection	1
101111	NT2/D1	1
101111	resemble	1
101111	paxillin-containing	1
101111	CBP)	1
101111	Ykt6pN	1
101111	viability.	1
101111	disintegrations	1
101111	verprolin's	1
101111	length.	1
101111	ts	1
101111	thymidylate	1
101111	BALB/c	1
101111	adenine	1
101111	presynaptic	1
101111	clinico-pathological	1
101111	MAb	1
101111	shear-sensitive	1
101111	magnesium	1
101111	abrogated	1
101111	Unlike	1
101111	excess.	1
101111	MeG	1
101111	actin-T	1
101111	longus	1
101111	insulin-like	1
101111	106	1
101111	CV-1	1
101111	125-week-old	1
101111	granulosa	1
101111	Co-precipitation	1
101111	LIMK's	1
101111	myocytes	1
101111	LAM	1
101111	MET15	1
101111	nerve	1
101111	rod-like	1
101111	HHUA/chr.2	1
101111	Jurkat	1
101111	HL-60	1
101111	patchlike	1
101111	radiation-induced	1
101111	Gel	1
101111	A-SMase.	1
101111	double-stranded	1
101111	of,	1
101111	H2981	1
101111	operative	1
101111	MDCK	1
101111	No	2
101111	epistasis	2
101111	ES	2
101111	core,	2
101111	A23R	2
101111	Physarum,	2
101111	cadherin-mediated	2
101111	vasodilator-stimulated	2
101111	Escherichia	2
101111	During	2
101111	endocytosis.	2
101111	mitotic	2
101111	acetyllysine	2
101111	IL-2	2
101111	COS-7	2
101111	125I-labeled	2
101111	eukaryal	2
101111	satellite	2
101111	whole	2
101111	myogenic	2
101111	squamous	2
101111	receptor-associated	2
101111	myocyte	2
101111	microM).	2
101111	cadherins.	2
101111	2.0	2
101111	PtK2	2
101111	multigene	2
101111	weaker	2
101111	double	2
101111	nonhomologous	3
101111	RNA-binding	3
101111	epidermal	3
101111	immunofluorescence	4
101111	breast	4
101111	insect	4
101111	86,	4
101111	MSH2-dependent	4
101111	culture	4
101111	biochemical	4
101111	day	4
101111	E.	5
101111	primary	5
101111	rod	6
101111	double-strand	7
101111	cultured	7
101111	addition,	8
101111	brush	8
101111	epithelial	10
101111	thymosin	10
101111	several	11
101111	replication	14
101111	no	14
101111	endothelial	15
101111	acid	15
101111	these	75
101111	this	59
11000	divalent-cation-binding	1
11000	proliferative	1
11000	Arabidopsis	1
11000	cone	1
11000	analysis.	1
11000	extent.	1
11000	(PI)	1
11000	myosin.	1
11000	H2A.1,	1
11000	(PPP),	1
11000	1-integrin.	1
11000	H1(0),	1
11000	phosphates.	1
11000	growth,	1
11000	4Xen	1
11000	motor	1
11000	H3;	1
11000	(1993)	1
11000	H1	1
11000	end-joining	1
11000	repair:	1
11000	healing	1
11000	RAD6,	1
11000	factor-stimulated	1
11000	masses	1
11000	extracts,	1
11000	cortex.	1
11000	H2A.Z,	1
11000	screening	1
11000	invasion	1
11000	insult	1
11000	cancers.	1
11000	tuft	1
11000	(H3+H4)2tetramers.	1
11000	SpA	1
11000	sheet;	1
11000	kinetics	1
11000	finding	1
11000	cycle.	1
11000	RAD2,	1
11000	1-integrin,	1
11000	transcribed	1
11000	CD31	1
11000	rounding	1
11000	unwinding	1
11000	ADP-ribosylated	1
11000	cycle-dependent	1
11000	order:	1
11000	AVMs,	1
11000	zur	1
11000	non-homologous	1
11000	H2B.1	1
11000	replication.	1
11000	(P;	1
11000	population	1
11000	factor-I,	1
11000	damage-induced	1
11000	1-syntrophin.	1
11000	H1,	1
11000	SNAREs	1
11000	H2A.X,	1
11000	4,5-bisphosphate,	1
11000	cyclin,	1
11000	H1.	1
11000	pombe.	1
11000	biopsies.	1
11000	cycle-related	1
11000	hormone	1
11000	cones,	1
11000	Kuhara,	1
11000	junctions.	1
11000	4),	1
11000	adhesiveness	1
11000	viruses,	1
11000	H3.	1
11000	margins	1
11000	4,	1
11000	cones.	1
11000	estrogen	1
11000	monitoring	1
11000	healing;	1
11000	hyperosmotic	1
11000	factor-165.	1
11000	wild	1
11000	viability	1
11000	CDK	1
11000	MgATPase	1
11000	subfractions	1
11000	viruses	1
11000	replication-specific	1
11000	(Tenney,	1
11000	distances,	1
11000	HBx	1
11000	breaks.	1
11000	morphology,	1
11000	kinds	1
11000	KB	1
11000	factors,	1
11000	adhesion-dependent	1
11000	measurement;	1
11000	cardiomyocytes	1
11000	eccentric	1
11000	2-	1
11000	1-syntrophin,	1
11000	embryos.	1
11000	phase	2
11000	junctions	2
11000	functions.	2
11000	contacts,	2
11000	amplification	2
11000	H2A	2
11000	armadillo	2
11000	material	2
11000	exchange,	2
11000	H2A.2,	2
11000	affinity,	2
11000	cells;	2
11000	cones	2
11000	KO	2
11000	line	2
11000	H2B,	2
11000	ratios	2
11000	K.,	2
11000	border.	2
11000	discontinuous	2
11000	caldesmon,	2
11000	25	2
11000	periphery	2
11000	gap	2
11000	morphology	2
11000	melanocytes.	2
11000	muscles	2
11000	appropriate	2
11000	peripheral	2
11000	subfractions,	2
11000	screen	2
11000	recognition	2
11000	genes:	2
11000	18	2
11000	membrane,	2
11000	weights	2
11000	adhesions.	3
11000	syncytial	3
11000	H2a	3
11000	L.,	3
11000	factor.	3
11000	divalent	3
11000	stage	3
11000	H4.	3
11000	lines,	3
11000	H2b	3
11000	ratio	3
11000	transformation	3
11000	adhesions	3
11000	use	3
11000	4,5-bisphosphate	3
11000	bundling	3
11000	junction	3
11000	pombe	3
11000	types	3
11000	neither	3
11000	adhesion,	3
11000	steady	3
11000	cerevisiae.	4
11000	repair.	4
11000	Munc18-2	4
11000	lines.	4
11000	microvilli	4
11000	N	4
11000	overall	4
11000	junctions,	4
11000	weight	5
11000	P	5
11000	seven	5
11000	contacts	5
11000	H3,	5
11000	PMN	5
11000	(P),	5
11000	exchange.	5
11000	dephosphorylation	5
11000	contact	5
11000	carcinoma	6
11000	P,	6
11000	H4,	6
11000	damage	6
11000	system.	6
11000	lung	6
11000	system	8
11000	signal	8
11000	membrane.	8
11000	4	8
11000	cycle	9
11000	dissociation	9
11000	recombination	9
11000	death	10
11000	C-terminal	11
11000	each	12
11000	control	12
11000	independent	12
11000	lines	14
11000	exchange	14
11000	(P)	14
11000	cerevisiae	15
11000	H3	15
11000	four	15
11000	H4	16
11000	major	18
11000	most	18
11000	nuclear	20
11000	one	22
11000	adhesion	23
11000	membrane	25
11000	repair	26
11000	other	39
11000	cyclin	40
11000	two	66
110010	formation:	1
110010	crystals.	1
110010	(26.0	1
110010	(alpha-skA),	1
110010	held	1
110010	ED13	1
110010	elasticity	1
110010	distribution.	1
110010	monomer,	1
110010	multicellular	1
110010	([14C]	1
110010	latticework	1
110010	cross-bridges	1
110010	flow.	1
110010	Bet	1
110010	ribbons	1
110010	modeling	1
110010	mostly	1
110010	polarization.	1
110010	(20-40%).	1
110010	moved	1
110010	rods,	1
110010	polymers	1
110010	analogue	1
110010	Villin	1
110010	mutant,	1
110010	(Act88F)	1
110010	CNBr	1
110010	effected	1
110010	continued	1
110010	microfilaments.	1
110010	patches.	1
110010	analogs	1
110010	proteases	1
110010	fibroblastic	1
110010	and,	1
110010	directly.	2
110010	process.	2
110010	organization,	2
110010	nucleation.	2
110010	tracer	2
110010	but,	2
110010	isogenes	2
110010	(43	2
110010	depolymerization	2
110010	motility.	2
110010	spectrum	2
110010	incorporated	2
110010	Ca2+,	2
110010	cytoarchitecture	2
110010	occurs	2
110010	gene.	2
110010	WASp	2
110010	microfilament	2
110010	dynamics,	2
110010	networks.	2
110010	meshwork	2
110010	organization.	2
110010	rates.	2
110010	crystals	3
110010	monomers.	3
110010	cardiomyopathy	3
110010	content	3
110010	hydrolysis	3
110010	(alpha-SMA),	3
110010	phenotype.	3
110010	tails	3
110010	lesions	3
110010	isoforms.	3
110010	dynamics.	3
110010	filament.	3
110010	monomers,	4
110010	mRNA	4
110010	polymerization,	4
110010	gamma	4
110010	binding.	5
110010	species	5
110010	tail	6
110010	patches	6
110010	microfilaments	7
110010	elongation	7
110010	assembly.	7
110010	null	7
110010	cytoskeleton,	7
110010	depolymerizing	8
110010	differentiation	8
110010	filaments,	8
110010	monomer	9
110010	dynamics	9
110010	motility	9
110010	bundles	10
110010	nucleation	10
110010	fibers	10
110010	mutation	11
110010	filaments.	11
110010	polymerization.	12
110010	monomers	12
110010	stress	12
110010	cytoskeleton.	16
110010	changes	17
110010	mutations	20
110010	cytoskeleton	21
110010	synthesis	23
110010	filament	29
110010	assembly	35
110010	filaments	41
110010	polymerization	38
1100110	box	1
1100110	Proteolytic	1
1100110	unique	1
1100110	aa	1
1100110	Cdc42p	1
1100110	excess	1
1100110	contrary	1
1100110	Panels	1
1100110	failure	1
1100110	somatomedin	1
1100110	(up	1
1100110	adhesion.	1
1100110	(Sac6p)-binding	1
1100110	(twofold	1
1100110	attach	1
1100110	animals.	1
1100110	seem	1
1100110	method	1
1100110	ceramide	1
1100110	propeller	1
1100110	GTP-binding	1
1100110	carboxy-terminal	1
1100110	immuno-EM	1
1100110	surface.	1
1100110	signal-regulated	1
1100110	Testicular	1
1100110	2.5-	1
1100110	terminus.	1
1100110	three-dimensional	1
1100110	chimeric	1
1100110	observing	1
1100110	confined	1
1100110	(threefold	1
1100110	dumbbell-shaped	1
1100110	myofibrillogenesis.	1
1100110	retina	1
1100110	adherence	1
1100110	nucleoside	1
1100110	attempt	1
1100110	(dfg)	1
1100110	according	1
1100110	35%,	1
1100110	TFIIIC	1
1100110	Pro1176	1
1100110	targeting	2
1100110	severing	2
1100110	relevant	2
1100110	every	2
1100110	zero	2
1100110	(P	2
1100110	differentially	2
1100110	vesicle	2
1100110	overproduction	2
1100110	general	2
1100110	except	2
1100110	N-WASP	2
1100110	equivalent	2
1100110	correlation	2
1100110	biological	2
1100110	anchorage	2
1100110	exposure	3
1100110	sensitivity	3
1100110	sequence.	3
1100110	proximal	3
1100110	rise	3
1100110	primarily	3
1100110	coding	3
1100110	55	3
1100110	analogous	3
1100110	network	3
1100110	contrast	4
1100110	disease	4
1100110	translocation	4
1100110	polymerase	4
1100110	coactivator	4
1100110	interacting	4
1100110	nucleus.	5
1100110	respect	5
1100110	order	5
1100110	probes	5
1100110	cross-linking	6
1100110	identical	6
1100110	corresponding	6
1100110	function.	6
1100110	up	7
1100110	some	7
1100110	leading	8
1100110	conserved	8
1100110	matrix	9
1100110	C	9
1100110	predicted	9
1100110	homology	10
1100110	small	10
1100110	response	11
1100110	peptide	11
1100110	addition	12
1100110	fusion	12
1100110	relative	13
1100110	ability	21
1100110	mutant	24
1100110	binding	119
1100110	affinity	30
1100111	4002).	1
1100111	full	1
1100111	negligible	1
1100111	disappearance	1
1100111	profilin-actin	1
1100111	minigenome.	1
1100111	cyanogen	1
1100111	E3L	1
1100111	injury	1
1100111	intensity	1
1100111	354:404-408.).	1
1100111	feature	1
1100111	CRE/CREB	1
1100111	SGE	1
1100111	PEPCK	1
1100111	potentiating	1
1100111	suggestion	1
1100111	origins	1
1100111	(COF1)	1
1100111	zero-length	1
1100111	atomic	1
1100111	Consistent	1
1100111	profilin-I;	1
1100111	1)	1
1100111	sedimentation,	1
1100111	liver	1
1100111	titrations,	1
1100111	cdc3+	1
1100111	crosslinker	1
1100111	p120cas	1
1100111	correlations	1
1100111	coreceptor	1
1100111	D)	1
1100111	Z.	1
1100111	over-expression	1
1100111	techniques,	1
1100111	consequence,	1
1100111	focused	1
1100111	Acanthamoeba-based	1
1100111	Kr	1
1100111	79-kDa	1
1100111	frequency-dependent	1
1100111	denominator	1
1100111	demonstration	1
1100111	current	1
1100111	MAbs	1
1100111	(ADA)	1
1100111	calreticulin	1
1100111	recombinants	1
1100111	relation	1
1100111	SAGA	1
1100111	RAD1-	1
1100111	mediator	1
1100111	(IGF-I)	1
1100111	implies	1
1100111	IRF1,	1
1100111	cadherin/catenin	1
1100111	(PFY1)	1
1100111	micro	1
1100111	labels,	1
1100111	assumption	1
1100111	Cof.	1
1100111	Linkage	1
1100111	exchanges	1
1100111	shortening	1
1100111	ABM-2	1
1100111	switch	1
1100111	derivatives	1
1100111	nonpolypotic	1
1100111	SE-11	1
1100111	ensuing	1
1100111	combined	1
1100111	H3:	1
1100111	inhibiting	1
1100111	Brca1	1
1100111	hypotheses	1
1100111	biologic	1
1100111	EF-1alpha	1
1100111	follicular	1
1100111	deleterious	1
1100111	Cotransfections	1
1100111	trimeric	1
1100111	Depending	1
1100111	drastic	1
1100111	modes	1
1100111	alpha-catenin/actin	1
1100111	lies	1
1100111	truncus	1
1100111	profiles	1
1100111	vessels	1
1100111	conversions	1
1100111	interplay	2
1100111	right	2
1100111	Treatment	2
1100111	(55.6	2
1100111	transactivation	2
1100111	Studies	2
1100111	UL9	2
1100111	CUS1.	2
1100111	heterotrimer	2
1100111	spatiotemporal	2
1100111	membranes.	2
1100111	clones	2
1100111	Most	2
1100111	hybridization	2
1100111	91	2
1100111	differs	2
1100111	frequency	2
1100111	constituent	2
1100111	separately	2
1100111	organisms	2
1100111	exon	2
1100111	chromatin	2
1100111	comparison	2
1100111	beginning	2
1100111	view	2
1100111	kIU.ml-1,	2
1100111	band	2
1100111	probe	2
1100111	established	3
1100111	kinetic	3
1100111	case	3
1100111	stretch	3
1100111	polarity	3
1100111	combination	3
1100111	fold	3
1100111	measure	3
1100111	epitopes	3
1100111	upstream	3
1100111	observation	3
1100111	capacity	3
1100111	relationship	3
1100111	regulators	3
1100111	Immunoprecipitation	3
1100111	colocalization	3
1100111	hypothesis	3
1100111	injection	3
1100111	sequences;	3
1100111	protein-protein	3
1100111	earlier	3
1100111	combinations	4
1100111	specificity	4
1100111	conversion	4
1100111	AAV	4
1100111	clone	4
1100111	based	5
1100111	possibility	5
1100111	fragment	5
1100111	promoter	5
1100111	isoform	5
1100111	heterotrimeric	5
1100111	differences	5
1100111	process	5
1100111	substrate	6
1100111	deaminase	6
1100111	sequences	7
1100111	product	7
1100111	defect	7
1100111	influence	7
1100111	components	9
1100111	complex,	9
1100111	helicase-primase	12
1100111	model	13
1100111	association	20
1100111	functions	20
1100111	complexes	22
1100111	interactions	22
1100111	effect	22
1100111	effects	24
1100111	interaction	40
1100111	complex	54
1100111	gene	45
11010	disturbance	1
11010	Recruitment	1
11010	grade	1
11010	Redistribution	1
11010	(SH3)	1
11010	foci.	1
11010	proportion	1
11010	evaluated,	1
11010	Replacement	1
11010	hours	1
11010	Reinvestigation	1
11010	tubules	1
11010	testis	1
11010	Abundance	1
11010	gels	1
11010	downregulation	1
11010	Production	1
11010	Generation	1
11010	augmentation	1
11010	editing	1
11010	indicator	1
11010	insertion	1
11010	subassembly	1
11010	background	1
11010	occurrence	1
11010	Associations	1
11010	frame	1
11010	polymerizability	1
11010	ectodomain	1
11010	3)	1
11010	C-terminus,	1
11010	labelling	1
11010	inactivation	1
11010	restructuration	1
11010	livers	1
11010	life-cycle	1
11010	transfection	1
11010	Study	1
11010	evaluation	1
11010	Suppression	1
11010	flux	1
11010	So	1
11010	ontogeny	1
11010	halves	1
11010	conformation	1
11010	interconversion	1
11010	regardless	1
11010	organisation	1
11010	permeability	1
11010	compartmentalization	1
11010	walls	1
11010	notion	1
11010	Immunolocalization	1
11010	mutagenesis	1
11010	acids)	1
11010	Expressions	1
11010	Coexpression	1
11010	dissolution	1
11010	determinants	1
11010	(87	1
11010	co-localization	1
11010	Mutants	1
11010	yields	1
11010	columns	1
11010	packing	1
11010	bromodomain	1
11010	measurement	1
11010	myotubule	1
11010	copies	1
11010	Co-localization	1
11010	permutation	1
11010	115	1
11010	mobilization	1
11010	relocalization	1
11010	enhancer	1
11010	infusion	1
11010	astroglia	1
11010	localisation	1
11010	pathogenesis	1
11010	subpopulation	1
11010	Z-discs	1
11010	re-expression	1
11010	IGF-I	1
11010	markers	1
11010	pre-spliceosome	1
11010	percentage	1
11010	bias	1
11010	arrival	1
11010	construction	1
11010	nature	1
11010	microsatellites	1
11010	counterparts	1
11010	definition	1
11010	Localization	1
11010	Lethality	1
11010	32%	1
11010	hour	1
11010	convergence	1
11010	Lack	1
11010	quantities,	1
11010	conjugation	1
11010	integrity	1
11010	X	1
11010	40-50%	1
11010	viscosity	1
11010	omission	1
11010	coexistence	1
11010	glomeruli	1
11010	depolymerisation	1
11010	Cys(SH1)	1
11010	sequestration	1
11010	preservation	1
11010	points	1
11010	macrophage,	1
11010	22%	1
11010	Evaluation	1
11010	Involvement	1
11010	10%	1
11010	self-association	1
11010	indicative	1
11010	Elevation	1
11010	context	1
11010	sequencing	1
11010	16kD	1
11010	regeneration	1
11010	dysfunction	1
11010	mediators	1
11010	N-terminus	1
11010	Exclusion	1
11010	subversion	1
11010	Inactivation	1
11010	subset	1
11010	Dispersal	1
11010	dissection	1
11010	acceleration	1
11010	Cys-374	1
11010	Digestion	1
11010	Determination	1
11010	gradient	1
11010	orders	1
11010	instead	1
11010	polarization	1
11010	Fusion	1
11010	interpretation	1
11010	Impact	1
11010	consequence	1
11010	off	1
11010	b	1
11010	80%	1
11010	86)	1
11010	mg	1
11010	quantification	1
11010	antigenicity	1
11010	slowing	1
11010	determination	2
11010	Requirement	2
11010	70%	2
11010	degree	2
11010	energy	2
11010	signals	2
11010	C-terminus	2
11010	cross-reactivity	2
11010	titration	2
11010	Purification	2
11010	Removal	2
11010	Loss	2
11010	redistribution	2
11010	characteristic	2
11010	enhancement	2
11010	deletions	2
11010	consisting	2
11010	series	2
11010	attachment	2
11010	quantity	2
11010	disruption	2
11010	ADP-ribosylation	2
11010	Exposure	2
11010	substrates	2
11010	consequences	2
11010	cultures	2
11010	detection	2
11010	stability	2
11010	populations	2
11010	built	2
11010	endocytosis	2
11010	expected,	2
11010	rearrangements	2
11010	Detection	2
11010	status	2
11010	374	2
11010	quantities	2
11010	nuclei	2
11010	modification	2
11010	foci	2
11010	anisotropy	2
11010	Transfection	2
11010	viscoelasticity	2
11010	dominant	2
11010	catenins,	2
11010	Binding	2
11010	maintenance	2
11010	Analyses	2
11010	units	2
11010	suppression	2
11010	morphogenesis	2
11010	doses	2
11010	ruffles	2
11010	orientation	2
11010	repeats	2
11010	characterization	2
11010	variety	2
11010	appearance	2
11010	member	3
11010	reactivity	3
11010	Regulation	3
11010	amount	3
11010	progression	3
11010	processing	3
11010	phenotypes	3
11010	step	3
11010	alleles	3
11010	roles	3
11010	down-regulation	3
11010	expressions	3
11010	contents	3
11010	period	3
11010	turnover	3
11010	Mechanism	3
11010	modulation	3
11010	(n	3
11010	pH	3
11010	areas	3
11010	Overexpression	3
11010	identification	3
11010	Phosphorylation	3
11010	digestion	3
11010	recruitment	3
11010	Addition	3
11010	strain	3
11010	analog	3
11010	Effects	4
11010	Deletion	4
11010	dosage	4
11010	release	4
11010	40%	4
11010	Isolation	4
11010	majority	4
11010	acetylation	4
11010	up-regulation	4
11010	lack	4
11010	fraction	4
11010	generation	4
11010	members	4
11010	activities	4
11010	downstream	4
11010	targets	4
11010	extent	4
11010	Interaction	5
11010	membranes	5
11010	induction	5
11010	characteristics	5
11010	development	5
11010	terminus	5
11010	basis	5
11010	incorporation	5
11010	repression	5
11010	coexpression	5
11010	disassembly	6
11010	composed	6
11010	amounts	6
11010	pool	6
11010	immunoprecipitation	6
11010	Inhibition	6
11010	importance	6
11010	microscopy	6
11010	Expression	6
11010	Characterization	6
11010	first	6
11010	organization	6
11010	level	7
11010	phenotype	7
11010	end	7
11010	consists	7
11010	action	7
11010	overexpression	7
11010	Analysis	7
11010	degradation	7
11010	cleavage	7
11010	pattern	8
11010	number	8
11010	part	8
11010	properties	8
11010	rates	8
11010	involvement	8
11010	component	9
11010	Kd	9
11010	stimulation	9
11010	regulator	10
11010	cytoplasm	10
11010	deletion	10
11010	reorganization	10
11010	accumulation	10
11010	loss	11
11010	surface	11
11010	family	11
11010	mechanism	11
11010	inhibition	13
11010	products	13
11010	ends	13
11010	concentrations	13
11010	absence	13
11010	distribution	14
11010	concentration	14
11010	function	16
11010	analysis	17
11010	localization	18
11010	phosphorylation	18
11010	rate	19
11010	formation	19
11010	regulation	21
11010	activation	22
11010	levels	22
11010	presence	31
11010	role	31
11010	expression	87
11010	region	34
110110	(WASP)	1
110110	constituents	1
110110	Crystallization	1
110110	locus,	1
110110	agent.	1
110110	(235	1
110110	acetylase(s).	1
110110	outcome.	1
110110	data,	1
110110	phospholipids	1
110110	mAb,	1
110110	kinase-dependent	1
110110	(DE-cadherin),	1
110110	phosphorylates	1
110110	F,	1
110110	reading	1
110110	storage	1
110110	rad54Delta	1
110110	D-binding	1
110110	transcript,	1
110110	(alpha-cat)	1
110110	understood.	1
110110	pRB	1
110110	cosmid,	1
110110	rad54	1
110110	PDS1,	1
110110	absorbance	1
110110	metabolism.	1
110110	CONCLUSION:	1
110110	beta-chain	1
110110	neck,	1
110110	p160/SRC-1-interacting	1
110110	cysteine-histidine-rich	1
110110	similar,	1
110110	activation,	1
110110	capacity:	1
110110	bordering	1
110110	pocket	1
110110	(A)	1
110110	sequencing,	1
110110	domain"	1
110110	Misumi.	1
110110	spectrin,	1
110110	cytokines	1
110110	protein:	1
110110	blotting	1
110110	rad3-d	1
110110	shifts	1
110110	Arikawa,	1
110110	Native	1
110110	alpha-dependent	1
110110	(A-Cat)	1
110110	transcripts.	1
110110	(H),	1
110110	depolymerization.	1
110110	interval,	1
110110	cross-filaments	1
110110	fashion,	1
110110	bilayers.	1
110110	zipper,	1
110110	lipocyte,	1
110110	lamellae	1
110110	ages.	1
110110	[1][2][3][4][5].	1
110110	kinase/stress-activated	1
110110	P.D.,	1
110110	processes.	1
110110	MEC2	1
110110	loci,	1
110110	(PaTuII)	1
110110	pairing	1
110110	exudate,	1
110110	subunit,	1
110110	2-fold.	1
110110	Mf	1
110110	myocardium.	1
110110	cryomethods	1
110110	edge,	1
110110	(1988)	1
110110	spinal	1
110110	virus.	1
110110	women	1
110110	loop	1
110110	LIM-kinases	1
110110	defects,	1
110110	components.	1
110110	(BxPc3	1
110110	recycling	1
110110	caspases-8	1
110110	capacity.	1
110110	cofactors	1
110110	(plakoglobin),	1
110110	cleft.	1
110110	Tobacman,	1
110110	modules.	1
110110	protein;	1
110110	000	1
110110	cup	1
110110	exogeneous	1
110110	peptides.	1
110110	mURA3	1
110110	alpha-chain,	1
110110	(triton	1
110110	whorl	1
110110	S2	1
110110	muscle,	1
110110	manner;	1
110110	tsK	1
110110	dehydrogenase,	1
110110	RhoGAP	1
110110	S3A	1
110110	(Armadillo),	1
110110	transactivator.	1
110110	('-'	1
110110	downregulation.	2
110110	drug	2
110110	chromatography,	2
110110	GTPase	2
110110	cascade.	2
110110	pathways,	2
110110	embryos	2
110110	allergen.	2
110110	K114E	2
110110	pathway,	2
110110	mating	2
110110	C,	2
110110	regions,	2
110110	ring	2
110110	properties.	2
110110	development.	3
110110	hydrophobic	3
110110	receptors.	3
110110	interaction.	3
110110	site.	3
110110	site,	3
110110	region,	3
110110	nt	3
110110	CBP,	3
110110	region.	3
110110	turnover.	4
110110	sites.	4
110110	domains,	4
110110	reorganization.	4
110110	muscle.	4
110110	(M)	4
110110	kinases	4
110110	pathway.	4
110110	integrins,	4
110110	(F),	4
110110	UL52,	4
110110	domain,	5
110110	arrest	5
110110	domain.	5
110110	calcium	5
110110	kinase,	7
110110	factor,	7
110110	expression,	7
110110	(N)	10
110110	genes.	10
110110	protein.	11
110110	proteins.	17
110110	UL8,	18
110110	1	34
110110	protein,	43
110110	protein	170
110111	sphincter	1
110111	size	1
110111	A-cdk2,	1
110111	overlay	1
110111	21-amino	1
110111	RAD14	1
110111	depending	1
110111	Redundancy	1
110111	(50	1
110111	Role	1
110111	displacement	1
110111	(N;	1
110111	cations	1
110111	changes,	1
110111	ridges	1
110111	ruffling,	1
110111	0.1%	1
110111	partner	1
110111	291-330)	1
110111	parameters	1
110111	composition	1
110111	contributions	1
110111	viewed	1
110111	Vus	1
110111	capacities	1
110111	incubation	1
110111	anti-CD26	1
110111	MC159	1
110111	cooperativity	1
110111	(homologues	1
110111	transition	1
110111	(NHEJ)-defective	1
110111	Absence	1
110111	W,	1
110111	+	1
110111	microparticles	1
110111	chemoattractants	1
110111	ORC1	1
110111	fus1,	1
110111	import	1
110111	pronounced	1
110111	array	1
110111	events,	1
110111	(L;	1
110111	cross-linking.	1
110111	synapse.	1
110111	synapses	1
110111	E-Cdk2	1
110111	Identification	1
110111	groups	1
110111	Cys-55	1
110111	antigen.	1
110111	CCMs,	1
110111	(PI	1
110111	mechanisms	1
110111	BUD1/RSR1,	1
110111	requirements	1
110111	Fusiform	1
110111	asymmetry.	1
110111	values.	1
110111	364	1
110111	Immunocytochemical	1
110111	(R.	1
110111	Immunoblot	1
110111	genomes	1
110111	regulon	1
110111	(19	1
110111	(28	1
110111	catalyzed	1
110111	uptake	1
110111	divide	1
110111	discovered	1
110111	(e)	1
110111	distributions	1
110111	preparations	1
110111	furrow,	1
110111	Kumagai,	1
110111	diversity	1
110111	Interactions	1
110111	protein).	1
110111	Unexpectedly,	1
110111	antigen,	1
110111	Unmasking	1
110111	elements	1
110111	than,	1
110111	infoldings,	1
110111	msec,	1
110111	role,	1
110111	cables	1
110111	determinant	1
110111	behaviour	1
110111	death-inducing	1
110111	(60-80	1
110111	precursor	1
110111	compete	1
110111	organisms.	1
110111	Disruption	1
110111	mRNA,	1
110111	antiparallel	1
110111	(H119E)	1
110111	Shigella	1
110111	(47	1
110111	purpose	1
110111	constants	2
110111	manner	2
110111	motifs	2
110111	homeologous	2
110111	T-antigen	2
110111	breakdown	2
110111	outcome	2
110111	alteration	2
110111	significance	2
110111	preference	2
110111	side	2
110111	parameters,	2
110111	phosphoprotein,	2
110111	edge	2
110111	partners	2
110111	h)	2
110111	portion	2
110111	roles,	2
110111	value	3
110111	Cells	3
110111	homologues	3
110111	(Kd	3
110111	structurally	3
110111	element	3
110111	features	3
110111	competition	3
110111	subunit	3
110111	BNI1,	3
110111	marker	3
110111	pattern,	3
110111	(p	3
110111	production	3
110111	protein)	3
110111	motif	3
110111	cases	3
110111	patterns	4
110111	E	4
110111	polypeptide	4
110111	activity,	4
110111	sections	4
110111	surfaces	4
110111	ligands	4
110111	reduction	4
110111	proteolysis	4
110111	analyses	4
110111	transduction	4
110111	factors	4
110111	however,	5
110111	chromatography	5
110111	intermediate	5
110111	molecule	6
110111	position	6
110111	histones	6
110111	assays	6
110111	transport	6
110111	subunits	7
110111	structure	8
110111	antigen	9
110111	D1	9
110111	pathways	9
110111	regions	12
110111	staining	12
110111	pathway	12
110111	genes,	12
110111	isoforms	19
110111	molecules	19
110111	domains	20
110111	sites	23
110111	site	29
110111	sequence	31
110111	activity	32
110111	domain	40
110111	proteins	131
111000	p40,	1
111000	57/68	1
111000	myosin-II	1
111000	ferritin	1
111000	(IFM)-specific	1
111000	myosin	139
111000	Myosin	2
1110010	SMemb,	1
1110010	Arg-403-->Gln	1
1110010	IIB	1
1110010	(beta-MHC)	1
1110010	myofibroblasts	1
1110010	microscopic	1
1110010	scattering	1
1110010	myogenin,	1
1110010	chain;	1
1110010	B.	1
1110010	chain)	1
1110010	connexin	1
1110010	(195	1
1110010	II-B.	1
1110010	Death	1
1110010	anti-SM1	1
1110010	isoforms:	1
1110010	mRNAs,	1
1110010	RNAs	1
1110010	(SMHC)	1
1110010	markers,	1
1110010	(Mhc36B)	1
1110010	(alpha+beta)	1
1110010	(RT-PCR).	1
1110010	chain-positive	1
1110010	chain:	1
1110010	chains.	1
1110010	second	2
1110010	phosphorylatable	2
1110010	Genetic	2
1110010	messenger	2
1110010	reaction	3
1110010	isoforms,	3
1110010	microscopy,	4
1110010	(MHC),	4
1110010	chains,	4
1110010	B	5
1110010	chain.	5
1110010	chains	5
1110010	(MHC)	8
1110010	chain,	30
1110010	chain	92
1110011	MSH6.	1
1110011	lamin	1
1110011	p35,	1
1110011	(83.8%)	1
1110011	structure,	1
1110011	(TnI)	1
1110011	exhibits	1
1110011	DT40	1
1110011	(beta)	1
1110011	(heavy	1
1110011	Act88F	1
1110011	transcription-polymerase	2
1110011	electron	3
1110011	heavy-chain	4
1110011	heavy	120
1110011	light	20
1110100	rods.	1
1110100	X22	1
1110100	subsequently	1
1110100	rates,	1
1110100	investigations,	1
1110100	SH-1	1
1110100	interact.	1
1110100	fractionation,	1
1110100	(VE)	1
1110100	colocalizing	1
1110100	group	1
1110100	castellani	1
1110100	(PAA)	1
1110100	RRM	1
1110100	OBJECTIVE:	1
1110100	portions,	1
1110100	nature,	1
1110100	thermophila	1
1110100	LOH	1
1110100	allergen,	1
1110100	associations	1
1110100	RNA,	1
1110100	emanating	1
1110100	collagens	1
1110100	method,	1
1110100	tail,	1
1110100	isoform.	1
1110100	antigravin	1
1110100	polyamides	1
1110100	aggregation	1
1110100	(N-WASP),	1
1110100	Thr	1
1110100	(SM1,	1
1110100	migration	1
1110100	cut2-364	1
1110100	translocates	1
1110100	14.5	1
1110100	keratinocytes	1
1110100	extending	1
1110100	conduction,	1
1110100	SJL1	1
1110100	medium	1
1110100	cosedimented	1
1110100	models	1
1110100	33%)	1
1110100	(MHC-IIB)	1
1110100	narrow	1
1110100	rabbits	1
1110100	2186-2189).	1
1110100	namely	1
1110100	myometrium	1
1110100	trafficking	1
1110100	poly-(L)-proline	1
1110100	model,	1
1110100	question.	1
1110100	22%),	1
1110100	hundred	1
1110100	derived	1
1110100	(GTBP)	1
1110100	UBE2I	1
1110100	mixture	1
1110100	(TRAF-1,	1
1110100	processes,	1
1110100	clusters	1
1110100	[Chaussepied	1
1110100	ways	1
1110100	0811	1
1110100	(d)	1
1110100	(88	1
1110100	cAMP	1
1110100	"pancadherin"	1
1110100	81,723	1
1110100	HPIV-3	1
1110100	C/ATF	1
1110100	55%).	1
1110100	machinery,	1
1110100	increased,	1
1110100	cancer:	1
1110100	15	1
1110100	results,	1
1110100	French	1
1110100	sphingomyelinase.	1
1110100	secretion	1
1110100	co-localizing	1
1110100	skin	1
1110100	SMase	1
1110100	alpha-catenin-deficient	1
1110100	C)	1
1110100	monolayers	2
1110100	compartments	2
1110100	embryo	2
1110100	overlap	2
1110100	plasmids	2
1110100	agreement	2
1110100	borders,	2
1110100	border	2
1110100	microscope	2
1110100	conditions	2
1110100	transcripts	2
1110100	substitutions	2
1110100	beta(4),	2
1110100	way	2
1110100	agents	2
1110100	testes	2
1110100	carcinomas.	2
1110100	EGTA	2
1110100	sera	2
1110100	cadherins	2
1110100	They	2
1110100	beads	2
1110100	Ras	2
1110100	outer	2
1110100	KCl	2
1110100	U.ml-1)	2
1110100	beta(4)	2
1110100	carcinomas	2
1110100	conjunction	2
1110100	plasmid	2
1110100	Immunohistochemistry	2
1110100	0.5	2
1110100	effects.	2
1110100	(5	2
1110100	technique	2
1110100	years	2
1110100	tissues	2
1110100	neutrophils	2
1110100	structures,	3
1110100	breaks	3
1110100	coli	3
1110100	epithelium	3
1110100	polypeptides	3
1110100	methods,	3
1110100	silencing,	3
1110100	functions,	3
1110100	result	3
1110100	processes	3
1110100	rats	3
1110100	identity	3
1110100	map	3
1110100	peptides	3
1110100	work	3
1110100	initiation	3
1110100	movement	3
1110100	beta4	3
1110100	variants	3
1110100	specimens	3
1110100	electrophoresis	3
1110100	families	4
1110100	polyphosphoinositides	4
1110100	immunoreactivity	4
1110100	complexes.	4
1110100	spread	4
1110100	mRNAs	5
1110100	gene,	5
1110100	extracts	5
1110100	glucokinase	6
1110100	strains	6
1110100	respectively,	6
1110100	patients	6
1110100	microM	7
1110100	tissue	7
1110100	experiments	8
1110100	receptors	9
1110100	evidence	9
1110100	study,	9
1110100	assay	9
1110100	increases	11
1110100	structures	12
1110100	transcription	15
1110100	study	15
1110100	residues	18
1110100	mutants	19
1110100	isolated	20
1110100	profilins	23
1110100	genes	50
1110100	cells	94
1110101	ovary.	1
1110101	caspase-8.	1
1110101	fixation	1
1110101	maturing	1
1110101	electric	1
1110101	MSH3-deficient	1
1110101	'mild'	1
1110101	function;	1
1110101	single-stranded	1
1110101	overexpression.	1
1110101	rhodamine	1
1110101	(70.0	1
1110101	lysis-squirting.	1
1110101	domains.	1
1110101	knowledge,	1
1110101	L-10,	1
1110101	turkey	1
1110101	antisera.	1
1110101	p=0.014).	1
1110101	adult	1
1110101	phosphonoacetic	1
1110101	kinetics.	1
1110101	BMMC	1
1110101	fragments.	1
1110101	cables.	1
1110101	contraction.	1
1110101	'motility	1
1110101	(EGFR)	1
1110101	ability.	1
1110101	namely,	1
1110101	E-CDK2.	1
1110101	Brindle,	1
1110101	Kwok,	1
1110101	220-240	1
1110101	kD,	1
1110101	fetal,	1
1110101	mitogen-rich	1
1110101	fork.	1
1110101	suppression,	1
1110101	both.	1
1110101	374.	1
1110101	patients'	1
1110101	8806-8812].	1
1110101	with,	1
1110101	counterparts.	1
1110101	phosphoinositides,	1
1110101	D-cdk4.	1
1110101	gland.	1
1110101	myofibrils.	1
1110101	acetylcholine	1
1110101	myoblasts.	1
1110101	(PIP2).	1
1110101	dimethylsulfoxide.	1
1110101	pig.	1
1110101	rootlets,	1
1110101	assembled	1
1110101	allele,	1
1110101	10485-10489).	1
1110101	b/coagulation	1
1110101	archaeal	1
1110101	actin-membrane	1
1110101	I.R.	1
1110101	fibroblasts.	1
1110101	4.5	1
1110101	apparatus.	1
1110101	time.	1
1110101	seminiferous	1
1110101	amphiphysin	1
1110101	levels.	1
1110101	nucleorhabdovirus.	1
1110101	form,	1
1110101	tracts.	1
1110101	antagonist,	1
1110101	malformed	1
1110101	stiffness	1
1110101	establishment	1
1110101	IgA	1
1110101	subclinical	1
1110101	glomerulonephritis,	1
1110101	phi	1
1110101	problem,	1
1110101	Immediately	1
1110101	bodies.	1
1110101	pre-mRNA	1
1110101	divergent	1
1110101	cadmium	1
1110101	HECD-1	1
1110101	immunohistochemistry.	1
1110101	EF-hand	1
1110101	hairs	1
1110101	starvation	1
1110101	arrest.	1
1110101	bonds	1
1110101	hormone.	1
1110101	late-pregnant	1
1110101	ewes.	1
1110101	molecules.	1
1110101	E-dependent	1
1110101	endometrial	1
1110101	stereocilia.	1
1110101	materials.	1
1110101	rootlet	1
1110101	approaches.	1
1110101	angiosperms.	1
1110101	A:Tbeta4.	1
1110101	nM).	1
1110101	heart.	1
1110101	ZmPRO1.	1
1110101	alpha-actinin.	1
1110101	'severe'	1
1110101	opsonized	1
1110101	forms.	1
1110101	three.	1
1110101	presenilin	1
1110101	migration.	1
1110101	disrupting	1
1110101	controls.	1
1110101	plaques.	1
1110101	non-cancerous	1
1110101	switching.	1
1110101	polyphosphoinositides.	1
1110101	sciatic	1
1110101	ribs.	1
1110101	men.	1
1110101	(S-H)	1
1110101	profilin).	1
1110101	falling	1
1110101	1.9	1
1110101	E-associated	1
1110101	poorly	1
1110101	senescence,	1
1110101	illustrate	1
1110101	orientation.	1
1110101	reinvestigated.	1
1110101	(Suzuki	1
1110101	semilunar	1
1110101	lesions.	1
1110101	notochord.	1
1110101	gamma)	1
1110101	cytokeratin.	1
1110101	production.	1
1110101	alpha-helix.	1
1110101	Trp-356.	1
1110101	phagocytosis.	1
1110101	enzymic	1
1110101	suffered	1
1110101	(NHEJ).	1
1110101	5030-5035).	1
1110101	TPA.	1
1110101	Caenorhabditis	1
1110101	RTS	1
1110101	DNase.	1
1110101	p38	1
1110101	mutants.	1
1110101	metastasis.	1
1110101	vinculin;	1
1110101	spreads.	1
1110101	RAD52).	1
1110101	IL-6	1
1110101	parainfluenza	1
1110101	appearance.	1
1110101	fluorescence,	1
1110101	lymphocytes.	1
1110101	mRNAs.	1
1110101	Tseng,	1
1110101	D3/CDK4).	1
1110101	family.	1
1110101	stripes.	1
1110101	subacute	1
1110101	embryo.	1
1110101	space.	1
1110101	PCAF	1
1110101	puromycin	1
1110101	regions.	2
1110101	7,	2
1110101	concentration.	2
1110101	54/68	2
1110101	6	2
1110101	level.	2
1110101	calmodulin,	2
1110101	color	2
1110101	injury.	2
1110101	pollen.	2
1110101	arterial	2
1110101	D.,	2
1110101	cytoskeletons	2
1110101	cores	2
1110101	HPIV3	2
1110101	86	2
1110101	yeast,	2
1110101	necrosis	2
1110101	2.2	2
1110101	grade,	2
1110101	pathways.	2
1110101	KCl.	2
1110101	times	2
1110101	E/cyclin-dependent	2
1110101	p55	2
1110101	interactions.	2
1110101	mechanism.	2
1110101	calmodulin.	2
1110101	factors.	2
1110101	mRNA.	2
1110101	structure.	2
1110101	NRP1	2
1110101	treatment.	2
1110101	ATP.	2
1110101	control.	2
1110101	intrahepatic	2
1110101	characterized.	2
1110101	N-ethylmaleimide	2
1110101	RESULTS:	3
1110101	protein),	3
1110101	assays.	3
1110101	rats.	3
1110101	E-cadherin.	3
1110101	unchanged.	3
1110101	FADD.	3
1110101	1.5	3
1110101	C.	3
1110101	Other	3
1110101	maize	3
1110101	neutrophils.	3
1110101	D1.	3
1110101	molecule.	3
1110101	force	3
1110101	muscles.	3
1110101	extracts.	3
1110101	growth.	4
1110101	43	4
1110101	profilins.	4
1110101	substrates.	4
1110101	cancer.	4
1110101	colorectal	4
1110101	AND	4
1110101	immunofluorescence,	5
1110101	M.,	5
1110101	Fas,	5
1110101	2,	5
1110101	conditions.	6
1110101	I.	6
1110101	desmin,	6
1110101	fimbrin.	6
1110101	respectively.	7
1110101	beta-catenin.	7
1110101	antibody	8
1110101	1,	8
1110101	embryonic	9
1110101	activity.	10
1110101	vascular	10
1110101	fimbrin,	10
1110101	syntaxin	11
1110101	2	12
1110101	cofilin.	13
1110101	complex.	13
1110101	antibodies	27
1110101	cells.	39
1110101	actin.	44
1110101	actin,	56
11101100	arteries	1
11101100	MHCK	1
11101100	heterozygosity	1
11101100	DR5	1
11101100	PP1	1
11101100	chromosomal	1
11101100	elders	1
11101100	(-19%,-32%,	1
11101100	intermolecular	1
11101100	enthalpic	1
11101100	Neither	1
11101100	caldesmon	1
11101100	SMemb	1
11101100	rat.	1
11101100	[35S]methionine	1
11101100	promoter,	1
11101100	SNF2	1
11101100	cortexillin	1
11101100	(Sutoh	1
11101100	DAMGO	1
11101100	CBP/p300,	1
11101100	Cdk4	1
11101100	TESK1,	1
11101100	F0	1
11101100	origin	1
11101100	delta-catenin	1
11101100	effusions	1
11101100	E2A	1
11101100	(NRP1)	1
11101100	interfere	1
11101100	assembles	1
11101100	Rac	1
11101100	FADD),	1
11101100	lamellipodia,	1
11101100	interleukin-1alpha	1
11101100	recognizes	1
11101100	TNFR-1-	1
11101100	PtdIns-4,5-P2	1
11101100	V12Ras	1
11101100	VITF-3	1
11101100	Aip1	1
11101100	commercially	1
11101100	DR3,	1
11101100	mHip1R	1
11101100	saline	1
11101100	atrophy,	1
11101100	EID-1	1
11101100	MAT	1
11101100	0.04)	1
11101100	Stat1	1
11101100	losses	1
11101100	parent	1
11101100	profilin-I	1
11101100	polymerization).	1
11101100	CDC42Hs-WASp	1
11101100	strength	1
11101100	allergen;	1
11101100	allergens	1
11101100	mesotheliomas	1
11101100	collectively	1
11101100	short-term	1
11101100	individually	1
11101100	represent	1
11101100	rapamycin	1
11101100	former	1
11101100	profilin/barbed-end	1
11101100	LIMK1	1
11101100	underlie	1
11101100	mucosa	1
11101100	profilin-annexin	1
11101100	RAD50	1
11101100	TSH	1
11101100	peaks	1
11101100	microtubules	1
11101100	cdc12p	1
11101100	filamin	1
11101100	gives	1
11101100	65%	2
11101100	makes	2
11101100	myotubes	2
11101100	ZmPRO4	2
11101100	SIR4	2
11101100	TD77	2
11101100	WIP	2
11101100	TGFbeta	2
11101100	MV	2
11101100	TNF-alpha	2
11101100	PKC	2
11101100	susceptibility	2
11101100	GPIIb-IIIa	2
11101100	annexin	2
11101100	FLICE,	2
11101100	intrachromosomal	2
11101100	PFY1,	2
11101100	catenins	2
11101100	laminin	2
11101100	tubulin,	2
11101100	actobindin	2
11101100	decrease	2
11101100	chromosome	2
11101100	nucleotides	2
11101100	kidneys	2
11101100	myoblasts	2
11101100	AtFim1	2
11101100	VASP	2
11101100	tumours,	3
11101100	heart	3
11101100	pRb	3
11101100	actins	3
11101100	s-1	3
11101100	lipids	3
11101100	Data	3
11101100	Munc-18-2	3
11101100	NP	3
11101100	dystrophin	3
11101100	translation	3
11101100	verprolin	4
11101100	alpha-syntrophin	4
11101100	apoptosis	4
11101100	hearts	4
11101100	MSH3,	5
11101100	M	5
11101100	integrin	5
11101100	DNase	6
11101100	they	9
11101100	microM)	9
11101100	TRADD,	11
11101100	fimbrin	24
11101100	it	35
11101100	talin	36
11101100	cofilin	85
11101100	profilin	233
11101101	Myf-5	1
11101101	tau	1
11101101	elongation.	1
11101101	tubulin	1
11101101	cut2+	1
11101101	RAD25	1
11101101	MSH2-independent	1
11101101	vinculin)	1
11101101	mobile	1
11101101	BUD4	1
11101101	unphosphorylated	1
11101101	CAP2	1
11101101	vinculin-binding	1
11101101	Fas/APO1;	1
11101101	ezrin,	1
11101101	34-	1
11101101	HHR23B/p58	1
11101101	poly(L-proline),	1
11101101	Arp3;	1
11101101	HCS77/WSC1/SLG1	1
11101101	PDV	1
11101101	(MEK)	1
11101101	RAD59	1
11101101	CGA7,	1
11101101	caspase-8,	1
11101101	ORC5	1
11101101	4)	1
11101101	p120(Cas)	1
11101101	E62	1
11101101	hemagglutinin-neuraminidase	1
11101101	mitomycin	1
11101101	PIP2;	1
11101101	pp60src	1
11101101	agarose	1
11101101	9	1
11101101	neurites	1
11101101	hematoxylin	1
11101101	2.3:1	1
11101101	Cdc6	1
11101101	W3N	1
11101101	TRAIL-R2)	1
11101101	actin-monomers	1
11101101	186	1
11101101	cloning	1
11101101	temporal	1
11101101	gelatin	1
11101101	END6/RVS161	1
11101101	6621-7210,	1
11101101	a/CUB	1
11101101	HPLC	1
11101101	58%	1
11101101	117	1
11101101	ROCK	1
11101101	Bnr1p	1
11101101	catabolism	1
11101101	MAD3	1
11101101	alkaline	1
11101101	contralateral	1
11101101	p33,	1
11101101	immunogold	1
11101101	thin,	1
11101101	multidomain	1
11101101	Demembranated	1
11101101	cross-reactive	1
11101101	terminate	1
11101101	RIP)	1
11101101	carbodiimide.	1
11101101	E2F	1
11101101	beta1-integrin.	1
11101101	release,	1
11101101	-10	1
11101101	SMemb.	1
11101101	accumulated	1
11101101	RIA	1
11101101	targeted	1
11101101	esophagus	1
11101101	sixfold),	1
11101101	Aip1.	1
11101101	B1	1
11101101	cadherin-5	1
11101101	freeze-substituted	1
11101101	frozen	1
11101101	colonic	1
11101101	Southern	1
11101101	acetylcholinesterase	1
11101101	gamma-catenin)	1
11101101	thicker	1
11101101	SM2	1
11101101	HHF35	1
11101101	LV	1
11101101	carboxyl-	1
11101101	polyadenylated	1
11101101	alphaV	1
11101101	destrin	1
11101101	RAIDD	1
11101101	p14	1
11101101	50K	1
11101101	4b	1
11101101	non-structural	1
11101101	66%	1
11101101	SM2)	1
11101101	solation,	1
11101101	microgram/mg	1
11101101	compaction,	1
11101101	PRP21)	1
11101101	CYBB	1
11101101	I.,	1
11101101	verprolin)	1
11101101	utrophin)	1
11101101	ERK1/2,	1
11101101	N-	1
11101101	ATP,	1
11101101	guidance,	1
11101101	msh3,	1
11101101	survival	1
11101101	USF-nucleosome	1
11101101	liver-	1
11101101	dimethylsulfoxide	1
11101101	-73%,	1
11101101	rhp54	1
11101101	(VE-cadherin)	1
11101101	intestine	1
11101101	rigidity	1
11101101	"bait,"	1
11101101	CD44v10,	1
11101101	cross-linking,	1
11101101	synaptogenesis.	1
11101101	crest	1
11101101	fasted	1
11101101	younger	1
11101101	lie	1
11101101	solvent	1
11101101	85%	1
11101101	BUD4,	1
11101101	Reed-Sternberg	1
11101101	peripheral,	1
11101101	gland	1
11101101	Mg+2)	1
11101101	10381-11133)	1
11101101	vice	1
11101101	IC	1
11101101	rad57	1
11101101	laminin)	1
11101101	TIF35	1
11101101	5.8S	1
11101101	stresses	1
11101101	peptide,	1
11101101	N10	1
11101101	rad22+	1
11101101	BTG	1
11101101	medium.	1
11101101	HMP-2,	1
11101101	p57,	1
11101101	TNF-induced	1
11101101	decreases	1
11101101	hypertrophy	1
11101101	MRS5	1
11101101	vertebrates	1
11101101	RAD23	1
11101101	maximum	1
11101101	LIMK1-,	1
11101101	sphincter,	1
11101101	CDV	2
11101101	NAC	2
11101101	RVS161	2
11101101	lamellipod	2
11101101	ATP-binding	2
11101101	PD81,723	2
11101101	virus,	2
11101101	AO	2
11101101	fimbrins	2
11101101	c-erbB2	2
11101101	poly(L-proline)	2
11101101	mispairs	2
11101101	beta-catenin;	2
11101101	ICP8	2
11101101	together,	2
11101101	MLH1	2
11101101	MyoD	2
11101101	(9%)	2
11101101	E-CD	2
11101101	nucleus	2
11101101	CD44	2
11101101	phagocytic	2
11101101	PtdIns(4,5)P2	2
11101101	gelsolin.	2
11101101	RAD57	2
11101101	srs2Delta	2
11101101	p120	2
11101101	synaptic	2
11101101	Y.	2
11101101	beta-catenin/plakoglobin	2
11101101	p130	2
11101101	left	2
11101101	wt)	2
11101101	actin)	2
11101101	A8R	3
11101101	BRCA2	3
11101101	srs2	3
11101101	PRP9	3
11101101	silent	3
11101101	alpha-actinin	3
11101101	BRCA1	3
11101101	calmodulin	3
11101101	cofilin/ADF	3
11101101	II,	3
11101101	phosphoinositide-binding	3
11101101	fibroblasts	3
11101101	ORC4	3
11101101	SIR4,	3
11101101	N-cadherin	3
11101101	hence	3
11101101	beta-catenin)	3
11101101	HSH49	3
11101101	PRP11	3
11101101	p53	4
11101101	UL42,	4
11101101	L	4
11101101	SIR1	4
11101101	actin-	4
11101101	PIP	4
11101101	PRP21	4
11101101	RIP	5
11101101	alpha-	5
11101101	desmin	5
11101101	shock	5
11101101	APC	6
11101101	PIP2	6
11101101	greater	6
11101101	p27	6
11101101	extracellular	6
11101101	FADD	7
11101101	UL5	7
11101101	villin	7
11101101	poly-L-proline	8
11101101	RAD54	10
11101101	gamma-catenin	12
11101101	MSH6	12
11101101	RAD52,	12
11101101	MSH3	12
11101101	MSH2	16
11101101	gelsolin	17
11101101	vinculin	19
11101101	plakoglobin	19
11101101	RAD52	22
11101101	UL52	22
11101101	RAD51	29
11101101	E-cadherin	33
11101101	beta-catenin	86
11101101	alpha-catenin	69
11101110	furrows.	1
11101110	activities,	1
11101110	maintains	1
11101110	LIMK2.	1
11101110	withstand	1
11101110	114,000.	1
11101110	cancers,	1
11101110	Tcf-4,	1
11101110	fibronectin,	1
11101110	angiogenesis.	1
11101110	SSB,	1
11101110	Hamatake,	1
11101110	4a	1
11101110	alpha-catenin:	1
11101110	inactivates	1
11101110	Three-dimensional	1
11101110	MRS11,	1
11101110	(HSP)-60,	1
11101110	pfy1-4,	1
11101110	act1-157,	1
11101110	micrograms/mg	1
11101110	(MEK1/2)	1
11101110	Herskowitz.	1
11101110	destrin.	1
11101110	139	1
11101110	(UL9),	1
11101110	(VEGFR-2).	1
11101110	mgt1delta	1
11101110	invasion,	1
11101110	adenocarcinomas.	1
11101110	assay'.	1
11101110	PLC-delta,	1
11101110	Mr	1
11101110	(265-kDa	1
11101110	Goodman,	1
11101110	SDS-PAGE.	1
11101110	furrow.	1
11101110	Spontaneous	1
11101110	Targeting	1
11101110	Single-headed	1
11101110	superior	1
11101110	Fas/APO1	1
11101110	microtubules,	1
11101110	ICSBP.	1
11101110	talin;	1
11101110	V3,	1
11101110	Actophorin	1
11101110	PMS2,	1
11101110	BUD5.	1
11101110	remove	1
11101110	proliferation.	1
11101110	T3M4).	1
11101110	3),	1
11101110	lesion:	1
11101110	(ABP1),	1
11101110	57	1
11101110	poly-L-proline.	1
11101110	cdc8,	1
11101110	(CAP1	1
11101110	(Muhlrad,	1
11101110	given	1
11101110	Monocytes	1
11101110	130	1
11101110	Sac6p,	1
11101110	compatible.	1
11101110	filamin),	1
11101110	G1/S/G2	1
11101110	OBJECTIVES:	1
11101110	folliculogenesis.	1
11101110	[2-4].	1
11101110	GIC1,	1
11101110	19.5.	1
11101110	HSP70.	1
11101110	zyxin,	1
11101110	Microinjection	1
11101110	4,5-P2)	1
11101110	filamin.	1
11101110	blocker),	1
11101110	diltiazem.	1
11101110	paxillin,	1
11101110	Heilbronn	1
11101110	pan-desmoglein	1
11101110	143	1
11101110	homology,	1
11101110	UL18.	1
11101110	haemagglutinin-neuraminidase	1
11101110	Mdm20p,	1
11101110	helicase-primase.	1
11101110	PRP11.	1
11101110	ERK1	1
11101110	myogenin.	1
11101110	glial	1
11101110	laminin,	1
11101110	(TNFR1)	1
11101110	GAL4,	1
11101110	coronin.	1
11101110	verprolin.	1
11101110	Latrunculin-A	1
11101110	shortened	1
11101110	essential.	1
11101110	Bni1p	1
11101110	UL29,	1
11101110	SIR4.	1
11101110	p27kip,	1
11101110	phenotypes,	1
11101110	CTNNB1	1
11101110	K03H1.10	1
11101110	PMS1,	1
11101110	MEC3.	1
11101110	CDC42Hs	1
11101110	25%.	1
11101110	lymphocyte	1
11101110	(DRP	1
11101110	Mhc36B-/+;	1
11101110	destrin,	1
11101110	sequestered	1
11101110	constant,	1
11101110	them.	1
11101110	hydroxyapatite.	1
11101110	metastases.	1
11101110	(4A6)	1
11101110	Sla2p.	1
11101110	folds	1
11101110	polarize.	1
11101110	daltons).	1
11101110	expresses	1
11101110	pool.	1
11101110	L-isoaspartyl	1
11101110	hCG.	1
11101110	PKR.	1
11101110	(End5p	1
11101110	strain,	1
11101110	(70-150	1
11101110	Discrete	1
11101110	9.	1
11101110	patients.	1
11101110	4,5-biphosphate	1
11101110	dependent.	1
11101110	(ABP),	1
11101110	subunits.	1
11101110	168	1
11101110	(TRAIL-R1	1
11101110	NR1.	1
11101110	sac6,	1
11101110	(ABP)	1
11101110	dephosphorylation.	1
11101110	pH.	1
11101110	PIP2,	1
11101110	tissue.	1
11101110	differentiation.	1
11101110	CC.	1
11101110	phosphoinositides.	1
11101110	pre-mRNA.	1
11101110	CapG	1
11101110	others	2
11101110	receptor,	2
11101110	polyproline	2
11101110	rather	2
11101110	Cofilin	2
11101110	KKRKK	2
11101110	MSH3.	2
11101110	FADD/MORT1	2
11101110	smoothelin,	2
11101110	4.	2
11101110	VASP,	2
11101110	SIR3,	2
11101110	(NP)	2
11101110	so	2
11101110	Abp1p	2
11101110	actin-bound	2
11101110	RIP.	2
11101110	RAD57,	2
11101110	gelsolin,	2
11101110	filamin,	2
11101110	Physarum	2
11101110	added	2
11101110	FAP,	2
11101110	SIR3	2
11101110	CD34,	2
11101110	measles	2
11101110	MgCl2.	3
11101110	cytoskeletons.	3
11101110	p300	3
11101110	48	3
11101110	Proc.	3
11101110	SIR2,	3
11101110	Abp1p,	3
11101110	vinculin.	3
11101110	tropomyosin.	3
11101110	RAD55	3
11101110	vimentin,	3
11101110	Human	3
11101110	monocytogenes	3
11101110	RAD52.	4
11101110	UL52)	4
11101110	gamma-catenin,	4
11101110	include	4
11101110	MLH1,	4
11101110	gene;	4
11101110	L.	4
11101110	myosin,	5
11101110	promoting	5
11101110	vimentin	5
11101110	UL9,	5
11101110	ADF	6
11101110	RAD54,	7
11101110	talin.	7
11101110	alpha-catenin.	9
11101110	TRADD	10
11101110	plakoglobin.	11
11101110	vinculin,	13
11101110	cofilin,	24
11101110	talin,	30
11101110	profilin,	43
11101110	profilin.	31
11101111	MKK1	1
11101111	5S,	1
11101111	Mg2+	1
11101111	ticks	1
11101111	(VEGF165)	1
11101111	RAD14,	1
11101111	cadherin-11	1
11101111	86),	1
11101111	pp60(c-src)	1
11101111	PIP2-stimulated	1
11101111	90	1
11101111	Nickel	1
11101111	acids	1
11101111	EHNA,	1
11101111	ITU,	1
11101111	draflazine,	1
11101111	W	1
11101111	poly)phosphoinositide)s	1
11101111	tyrosine-autophosphorylation	1
11101111	domain)	1
11101111	FAF.	1
11101111	[P(NJ)]	1
11101111	X-rays.	1
11101111	phocid	1
11101111	IB,	1
11101111	[Activation	1
11101111	(MEKK)	1
11101111	505	1
11101111	entropic	1
11101111	NRP1.	1
11101111	neuronal	1
11101111	c-Myc	1
11101111	live	1
11101111	SNF2.	1
11101111	i.e.	1
11101111	PKC-delta.	1
11101111	collapsin-1	1
11101111	livers,	1
11101111	threonine	1
11101111	2mM	1
11101111	poly-l-proline	1
11101111	P-cadherin,	1
11101111	compared,	1
11101111	vasculogenesis	1
11101111	sonchus	1
11101111	contraction	1
11101111	(flk-1/KDR)	1
11101111	VEGF-receptor-2	1
11101111	regulates,	1
11101111	podocytes	1
11101111	1:3	1
11101111	cdc3	1
11101111	leech	1
11101111	intra-	1
11101111	infectious	1
11101111	GCD10,	1
11101111	pan-desmocollin	1
11101111	(VE)-cadherin,	1
11101111	phosphatidylinositol-4,5-bisphosphate	1
11101111	efficiently	1
11101111	BCK1	1
11101111	BUB3,	1
11101111	(ITU,	1
11101111	iodotubercidin	1
11101111	abnormal	1
11101111	S-type	1
11101111	HSP27	1
11101111	differentiating	1
11101111	coevolved	1
11101111	(CKs)	1
11101111	cytokeratins	1
11101111	(against	1
11101111	syntrophin	1
11101111	triplet,	1
11101111	(E-CD)	1
11101111	phosphoinositides	1
11101111	TNFR1(p55),	1
11101111	c-fos	1
11101111	min-1)	1
11101111	kg-1.	1
11101111	microgram.	1
11101111	[3H]	1
11101111	Immunoreactive	1
11101111	integrin,	1
11101111	beta1	1
11101111	15),	1
11101111	p120(cas)	1
11101111	rad55	1
11101111	pollen:	1
11101111	angiosperm	1
11101111	XPC.	1
11101111	cardiocyte	1
11101111	SM1	1
11101111	cycloheximide,	1
11101111	cut1	1
11101111	msh2,	1
11101111	activities.	1
11101111	assembly,	1
11101111	cut1+	1
11101111	cadherins,	1
11101111	1,3-dipropyl-8-cyclopentylxanthine	1
11101111	U/ml)	1
11101111	11)	1
11101111	gel-purified	1
11101111	BAX,	1
11101111	CdCl2,	1
11101111	endocytosis,	1
11101111	Vimentin	1
11101111	ultrastructure	1
11101111	Thymosin-beta4.Actin).	1
11101111	acumentin	1
11101111	becomes	1
11101111	beta-catenin/Armadillo,	1
11101111	efficient.	1
11101111	diethylstilboestrol	1
11101111	survivors,	1
11101111	LEF-1	1
11101111	hereditary	1
11101111	alpha5	1
11101111	homothallic	1
11101111	glomerulonephritis	1
11101111	Full-length	1
11101111	capsid	1
11101111	pan-cadherin,	1
11101111	interchromosomal	1
11101111	nonplant	1
11101111	TNFR1	2
11101111	defects	2
11101111	magnitude	2
11101111	minutes	2
11101111	gamma-catenin.	2
11101111	junctional	2
11101111	PRP11,	2
11101111	8-cyclopentyltheophylline	2
11101111	PRT1	2
11101111	dystrophin,	2
11101111	recombination,	2
11101111	fed	2
11101111	APC,	3
11101111	VE-cadherin,	3
11101111	E-cad,	3
11101111	p120,	3
11101111	N-cadherin,	6
11101111	cadherin	7
11101111	plakoglobin,	9
11101111	beta-catenin,	61
11101111	alpha-catenin,	65
11101111	E-cadherin,	38
1111000	plaques)	1
1111000	Pol,	1
1111000	Iida,	1
1111000	complexes).	1
1111000	asked	1
1111000	demonstrating	1
1111000	(EGF),	1
1111000	(SV40)	1
1111000	unlikely	1
1111000	MluI;	1
1111000	reports	1
1111000	assayed	1
1111000	p55-R;	1
1111000	called	1
1111000	(VEGF),	1
1111000	believe	1
1111000	Myf5,	1
1111000	(XPD),	1
1111000	SMemb),	1
1111000	negatively	1
1111000	(range	1
1111000	74	1
1111000	number,	1
1111000	showing	1
1111000	concluded	1
1111000	work,	1
1111000	module	1
1111000	truncates	1
1111000	detect	1
1111000	check	1
1111000	rootlets	1
1111000	question	1
1111000	liver,	1
1111000	alpha,beta-methylene	1
1111000	elaborations	1
1111000	transferase	1
1111000	10(3)	1
1111000	verify	1
1111000	emphasize	1
1111000	SRV2,	1
1111000	phosphatases	1
1111000	speculate	2
1111000	propose	2
1111000	implying	2
1111000	analysis,	2
1111000	characterize	2
1111000	attribute	2
1111000	Korn,	2
1111000	p27(KIP1)	2
1111000	10(-3)	2
1111000	Sci.	2
1111000	precedes	2
1111000	10(-6)	2
1111000	Zhu,	2
1111000	95	2
1111000	kinase)	2
1111000	(iii)	2
1111000	IV,	2
1111000	describe	3
1111000	confirm	3
1111000	clarify	3
1111000	p27,	3
1111000	000)	3
1111000	test	3
1111000	find	3
1111000	identify	3
1111000	(ADF),	3
1111000	provide	4
1111000	indicated	4
1111000	investigate	4
1111000	indicates	4
1111000	conclude	5
1111000	here	5
1111000	support	5
1111000	indicating	7
1111000	encode	8
1111000	report	8
1111000	demonstrate	11
1111000	suggests	12
1111000	suggesting	13
1111000	indicate	15
1111000	determine	16
1111000	revealed	17
1111000	showed	24
1111000	show	26
1111000	suggest	34
1111001	24:625-636].	1
1111001	(CKI).	1
1111001	RAD10,	1
1111001	(VEGF)	1
1111001	(DHFR),	1
1111001	Nishida,	1
1111001	immunoassays	1
1111001	binary	1
1111001	(TS),	1
1111001	effectively	1
1111001	G.	1
1111001	(Adams,	1
1111001	prolongation	1
1111001	28,	1
1111001	mutations.	1
1111001	taken	1
1111001	(p27Kip1):	1
1111001	sought	1
1111001	R.,	1
1111001	aggregates	1
1111001	p18,	1
1111001	peripherally	1
1111001	serotypes	1
1111001	p27KIP1	1
1111001	(CKI),	1
1111001	1989).	1
1111001	BUD8	1
1111001	Jersey	1
1111001	1.1:1	1
1111001	two-hybrid-based	1
1111001	removal	1
1111001	virion	1
1111001	365,	1
1111001	Hagiwara,	1
1111001	C.,	1
1111001	Karin,	1
1111001	relationships	1
1111001	comprising	1
1111001	ducts.	1
1111001	21,	1
1111001	pre-treatment	1
1111001	2.2-kb	1
1111001	125	1
1111001	extensor	1
1111001	Ser133-phosphorylated	1
1111001	(SSPE)	1
1111001	1.6-kb	1
1111001	Rep-3	1
1111001	ductal	1
1111001	Botstein,	1
1111001	Virol.	1
1111001	locus	1
1111001	RII.	1
1111001	370,	1
1111001	Cell	1
1111001	titin,	1
1111001	aimed	1
1111001	double-labeling	1
1111001	RAFT1,	1
1111001	RAD53,	1
1111001	nonpregnant	1
1111001	'+'	1
1111001	p57KIP2	1
1111001	CD44v7-8,	1
1111001	Roth	1
1111001	serum	1
1111001	correlates	1
1111001	rabbits.	1
1111001	Zealand	1
1111001	quiescent	1
1111001	(serum	1
1111001	reactive	1
1111001	extensively	1
1111001	improve	1
1111001	AP-1,	1
1111001	markedly	1
1111001	38	1
1111001	bacteria,	1
1111001	entirely	1
1111001	proteasome-mediated	1
1111001	0.3	1
1111001	0.4	1
1111001	19.1	1
1111001	1.8	1
1111001	establishes	1
1111001	cores,	1
1111001	(PNR),	1
1111001	TCC	1
1111001	red	1
1111001	Pollard,	1
1111001	cancers	1
1111001	exposure,	1
1111001	beneficial	1
1111001	TRAF-3)	1
1111001	p21(WAF1/CIP1)	1
1111001	minute	1
1111001	observations.	1
1111001	chimera	1
1111001	beta2	1
1111001	MCF-7	1
1111001	microgram	1
1111001	(CDKI),	1
1111001	(OZ).	1
1111001	p27(kip1)	1
1111001	committed	1
1111001	M:	1
1111001	Biol	1
1111001	then	1
1111001	(DPCPX),	1
1111001	SF3a,	1
1111001	(1983)	1
1111001	(tentatively	1
1111001	molecule);	1
1111001	viscometry,	1
1111001	Micheletti,	1
1111001	Ia/b	1
1111001	labeling,	1
1111001	p16ink4a	1
1111001	II-peptide	1
1111001	pull-down	1
1111001	LEF-1-dependent	1
1111001	partial	1
1111001	dictates	1
1111001	51,000,	1
1111001	(deltaN131,	1
1111001	Biochem.	1
1111001	(Abe	1
1111001	nodal	2
1111001	duct	2
1111001	ultracentrifugation,	2
1111001	al.	2
1111001	(1994)	2
1111001	(Lond.).	2
1111001	165	2
1111001	clearly	2
1111001	p27KIP1,	2
1111001	p53,	2
1111001	products,	2
1111001	crossovers,	2
1111001	thereby	2
1111001	conducted	2
1111001	p21,	2
1111001	tumors	2
1111001	(ADF)	2
1111001	hearts,	2
1111001	tagged	2
1111001	homolog	2
1111001	therefore	2
1111001	further	3
1111001	troponin	3
1111001	al.,	3
1111001	PRP9,	3
1111001	(1982)	3
1111001	prepared	3
1111001	RIP,	3
1111001	synthesis,	3
1111001	concentration-dependent	3
1111001	AP-1	4
1111001	probably	4
1111001	MSH6,	4
1111001	AP-1.	4
1111001	p21	4
1111001	immunohistochemically	5
1111001	Biol.	6
1111001	J.,	6
1111001	5	9
1111001	strongly	10
1111001	II	17
1111001	I	23
1111001	have	76
1111010	actin-cytoskeletons	1
1111010	performed.	1
1111010	behaves	1
1111010	intense	1
1111010	5-bisphosphate	1
1111010	preferred	1
1111010	cleaved	1
1111010	inhibited.	1
1111010	bond	1
1111010	injections,	1
1111010	suppressing	1
1111010	74-89%	1
1111010	A1-9.	1
1111010	different,	1
1111010	elucidated.	1
1111010	[P(I)]	1
1111010	defined	1
1111010	PKC1	1
1111010	flanked	1
1111010	supported	1
1111010	grew	1
1111010	Surprisingly,	1
1111010	well-characterized	1
1111010	mobilized	1
1111010	177	1
1111010	assessed.	1
1111010	(identified	1
1111010	assay'	1
1111010	achieved	1
1111010	deposited	1
1111010	kidney.	1
1111010	projections	1
1111010	carried	1
1111010	copurified	1
1111010	released.	1
1111010	polycistronic	1
1111010	2)	1
1111010	branching	1
1111010	interpret	1
1111010	reached	1
1111010	slightly,	1
1111010	sensed	1
1111010	acts	1
1111010	studied.	1
1111010	discussed	1
1111010	(OSM)	1
1111010	again	1
1111010	up-regulated,	1
1111010	selected	1
1111010	ranged	1
1111010	strictly	1
1111010	secreted	1
1111010	(A-SMase)	1
1111010	pH-dependent,	1
1111010	multifunctional,	1
1111010	present,	1
1111010	established,	1
1111010	Hypertonicity	1
1111010	co-regulated	1
1111010	reduced,	1
1111010	restored	1
1111010	observed,	1
1111010	cassette	1
1111010	(SMCs)	1
1111010	colonies,	1
1111010	quantified	1
1111010	found.	1
1111010	ill-defined:	1
1111010	suppressible	1
1111010	recovery,	1
1111010	useful	1
1111010	destrin/ADF	1
1111010	GAP	1
1111010	selective	1
1111010	forming,	1
1111010	cofilin;	1
1111010	monomer)	1
1111010	(100	1
1111010	low,	1
1111010	followed	1
1111010	triggered	1
1111010	modeled	1
1111010	dissociated	1
1111010	7471-7475].	1
1111010	operating	1
1111010	contributes	1
1111010	introduced	1
1111010	detectable.	1
1111010	identified,	1
1111010	stronger	1
1111010	interdigitated	1
1111010	scale	1
1111010	immunoreactivity,	1
1111010	critically	1
1111010	controversial.	1
1111010	rRNA	1
1111010	who	1
1111010	Thrombin,	1
1111010	minimal	1
1111010	1301-1700,	1
1111010	coordination	1
1111010	characterised	1
1111010	dimmer	1
1111010	traverse	1
1111010	domain'	1
1111010	overexpressed	1
1111010	banding	1
1111010	inviable.	1
1111010	translocate	1
1111010	(DSBs)	1
1111010	axis	1
1111010	unaffected	1
1111010	anlagen	1
1111010	residue)	1
1111010	differently	1
1111010	STE12,	1
1111010	ducts	1
1111010	comigrates	1
1111010	specific;	1
1111010	3'-N-4a-4b-M-G-L-5',	1
1111010	truncation	1
1111010	conserved,	1
1111010	designated	2
1111010	rich	2
1111010	indispensable	2
1111010	impaired	2
1111010	driven	2
1111010	promoted	2
1111010	maintained	2
1111010	modifications	2
1111010	ADF,	2
1111010	estimated	2
1111010	rescued	2
1111010	concentrated	2
1111010	resulted	2
1111010	myofibrils	2
1111010	constant	2
1111010	predominantly	2
1111010	reversed	2
1111010	synthesized	2
1111010	(ii)	2
1111010	even	2
1111010	contained	2
1111010	controlled	2
1111010	exists	2
1111010	manner,	3
1111010	confirmed	3
1111010	considered	3
1111010	smaller	3
1111010	lethal	3
1111010	engaged	3
1111010	transported	3
1111010	designed	3
1111010	constructed	3
1111010	distributed	3
1111010	recognized	3
1111010	approach	3
1111010	unchanged	3
1111010	tested	3
1111010	inserted	3
1111010	generated	4
1111010	change	4
1111010	prevented	4
1111010	studied	4
1111010	blocked	4
1111010	deficient	4
1111010	microinjected	4
1111010	manner.	4
1111010	performed	4
1111010	occurred	5
1111010	evaluated	5
1111010	located	5
1111010	suppressed	5
1111010	cross-linked	5
1111010	transfected	5
1111010	obtained	5
1111010	analysed	5
1111010	incubated	5
1111010	affected	5
1111010	defective	5
1111010	Mutations	5
1111010	produced	5
1111010	accompanied	6
1111010	reported	6
1111010	analyzed	6
1111010	necessary	6
1111010	formed	7
1111010	encoded	7
1111010	absent	7
1111010	participate	7
1111010	mediated	8
1111010	characterized	8
1111010	implicated	8
1111010	localized	8
1111010	suggested	8
1111010	investigated	10
1111010	seen	10
1111010	measured	10
1111010	detected	11
1111010	observed	12
1111010	examined	12
1111010	increase	14
1111010	present	15
1111010	used	17
1111010	demonstrated	17
1111010	determined	17
1111010	induced	19
1111010	expressed	24
1111010	shown	28
1111010	identified	31
1111010	involved	32
1111010	found	37
11110110	Results	1
11110110	recovered	1
11110110	assessed	1
11110110	separable	1
11110110	(34.0%)	1
11110110	(69.8%)	1
11110110	(66.0%)	1
11110110	inconsistent	1
11110110	Immunoreactivity	1
11110110	arguing	1
11110110	effectively.	1
11110110	fluorescencetitration	1
11110110	protected	1
11110110	contrasts	1
11110110	backbone	1
11110110	implications	1
11110110	fragmin	1
11110110	GBD-SIR1	1
11110110	react	1
11110110	'++'	1
11110110	cDNAs	1
11110110	copurifies	1
11110110	classical	1
11110110	patient	1
11110110	Compared	1
11110110	demonstrated.	1
11110110	laterally	1
11110110	treated	1
11110110	K(D)	1
11110110	inferred	1
11110110	co-localize	1
11110110	abnormalities	1
11110110	reservoir	1
11110110	A]	1
11110110	(37.7%)	1
11110110	rose	1
11110110	background)	1
11110110	SNAP-23	1
11110110	VEGF(121).	1
11110110	yeast.	1
11110110	bacteria.	1
11110110	2-3	1
11110110	communicate	1
11110110	deleted	1
11110110	Kd's--one	1
11110110	treatments,	1
11110110	immunoblotting	1
11110110	immunoprecipitates	1
11110110	column	1
11110110	reacted	1
11110110	search	1
11110110	hepatectomy.	1
11110110	substitute	1
11110110	interface	1
11110110	copurify	1
11110110	compensate	1
11110110	separated	1
11110110	codes	1
11110110	oxygen	1
11110110	progeny	1
11110110	ranging	1
11110110	5,	1
11110110	implication	1
11110110	concurrent	1
11110110	CD44,	1
11110110	co-infected	1
11110110	collaborated	1
11110110	hybridized	1
11110110	explanation	1
11110110	appreciable	2
11110110	transverse	2
11110110	prevent	2
11110110	arises	2
11110110	samples	2
11110110	stimulation.	2
11110110	positive	2
11110110	YACs	2
11110110	complexing	2
11110110	Scar	2
11110110	coincident	2
11110110	accounted	2
11110110	immunostaining	2
11110110	thymosin-beta4	2
11110110	correlate	3
11110110	similarity	3
11110110	pulmonary	3
11110110	cent)	3
11110110	account	3
11110110	stained	3
11110110	cent	3
11110110	expected	3
11110110	allows	3
11110110	complexed	4
11110110	competed	4
11110110	affinities	4
11110110	along	4
11110110	polarized	4
11110110	potential	4
11110110	co-localized	4
11110110	crucial	5
11110110	labeling	5
11110110	colocalized	5
11110110	associates	5
11110110	negative	6
11110110	correlated	6
11110110	treatment	9
11110110	critical	9
11110110	together	9
11110110	associate	9
11110110	distinct	10
11110110	interacts	10
11110110	consistent	11
11110110	compared	11
11110110	proposed	11
11110110	kDa	12
11110110	responsible	12
11110110	important	15
11110110	essential	17
11110110	interact	19
11110110	receptor	21
11110110	required	29
11110110	associated	29
11110111	Kovar	1
11110111	ever	1
11110111	PTCA-induced	1
11110111	achieved.	1
11110111	correlations.	1
11110111	(2000)	1
11110111	subsecond	1
11110111	cells'	1
11110111	80,000,	1
11110111	Drubin.	1
11110111	noted	1
11110111	smoothelin.	1
11110111	dose	1
11110111	AIMS:	1
11110111	species-specific.	1
11110111	suppress.	1
11110111	attached.	1
11110111	images	1
11110111	similar.	1
11110111	(Ad5).	1
11110111	contractility	1
11110111	47	1
11110111	treatment;	1
11110111	solution.	1
11110111	mM)	1
11110111	Alberts,	1
11110111	integral	1
11110111	855-859).	1
11110111	presumed	1
11110111	226-228;	1
11110111	Edman	1
11110111	blocked,	1
11110111	potentially	1
11110111	lacking,	1
11110111	3'UTI	1
11110111	III	1
11110111	collapsin-1/semaphorin	1
11110111	insufficient	1
11110111	conjugating	1
11110111	disrupted,	1
11110111	employed.	1
11110111	nonoverlapping	1
11110111	microM.	1
11110111	E2F-dependent	1
11110111	glands	1
11110111	indeed	1
11110111	696-702)	1
11110111	372:567-570).	1
11110111	t-SNARE	1
11110111	chemically	1
11110111	co-localized.	1
11110111	time-dependent	1
11110111	released,	1
11110111	despite	1
11110111	CHK1,	1
11110111	photobleaching	1
11110111	ATPase)	1
11110111	DFG9,	1
11110111	106,	1
11110111	reexamined.	1
11110111	in-frame	1
11110111	withdrawal.	1
11110111	lethal,	1
11110111	3.3-fold	1
11110111	us	1
11110111	2.4-fold	1
11110111	TNF-alpha-induced	1
11110111	77%	1
11110111	rarely	1
11110111	HNE	1
11110111	absent.	1
11110111	abolished.	1
11110111	identified:	1
11110111	employed	1
11110111	profilin)	1
11110111	rac-1	1
11110111	enabled	1
11110111	biochemically	1
11110111	'death	1
11110111	close	1
11110111	denser	1
11110111	observed.	1
11110111	perhaps	1
11110111	down-regulated.	1
11110111	G1/S	1
11110111	G0	1
11110111	rare	1
11110111	conformational	1
11110111	used.	1
11110111	Features	1
11110111	3571-4057,	1
11110111	270:19551-19556).	1
11110111	Chem	1
11110111	deeply	1
11110111	conformation.	1
11110111	heterogeneity.	1
11110111	survivors	1
11110111	Hurlburt,	1
11110111	capped.	1
11110111	protease-sensitive	1
11110111	KTLKK	1
11110111	complete.	1
11110111	negative.	1
11110111	identical;	1
11110111	proteolytically	1
11110111	unusual	1
11110111	random	1
11110111	believed	1
11110111	94,	1
11110111	allergies.	1
11110111	developmentally	2
11110111	unknown.	2
11110111	secondary	2
11110111	fused	2
11110111	1994).	2
11110111	assigned	2
11110111	subjected	2
11110111	nearly	2
11110111	D	2
11110111	glc7-10	2
11110111	dose-dependent	2
11110111	myotubes.	2
11110111	perpendicular	2
11110111	exposed	2
11110111	(c)	2
11110111	fashion	2
11110111	U2	2
11110111	snRNP	2
11110111	values	2
11110111	viable	2
11110111	identical,	2
11110111	immunologically	2
11110111	larger	2
11110111	extended	2
11110111	though	2
11110111	MEC3	2
11110111	remarkably	2
11110111	240	2
11110111	conditions,	2
11110111	monitored	2
11110111	stable	2
11110111	distantly	2
11110111	sensitive	2
11110111	compared.	2
11110111	made	2
11110111	quantitatively	3
11110111	eight	3
11110111	weak	3
11110111	MEC1,	3
11110111	due	3
11110111	led	3
11110111	rapidly	3
11110111	maximal	3
11110111	weakly	3
11110111	regulated,	3
11110111	serves	3
11110111	described	4
11110111	stimulated	4
11110111	striking	4
11110111	effect.	4
11110111	disrupted	4
11110111	unable	4
11110111	14	4
11110111	urea	4
11110111	time	5
11110111	apparently	5
11110111	possible	5
11110111	Chem.	5
11110111	recombination.	5
11110111	sufficient	6
11110111	cloned	6
11110111	able	6
11110111	significantly	7
11110111	completely	7
11110111	recently	7
11110111	enhanced	7
11110111	likely	9
11110111	regulated	9
11110111	dependent	11
11110111	highly	12
11110111	inhibited	13
11110111	reduced	14
11110111	previously	14
11110111	related	15
11110111	homologous	15
11110111	known	20
11110111	only	23
11110111	similar	30
11110111	increased	33
11110111	been	40
1111100	H2B	1
1111100	Biopsies	1
1111100	rad59	1
1111100	p19,	1
1111100	complex",	1
1111100	(P/V)	1
1111100	Immunoprecipitations	1
1111100	researchers	1
1111100	Bud-site	1
1111100	survival.	1
1111100	isopeptide	1
1111100	library,	1
1111100	Feramisco,	1
1111100	Coprecipitations	1
1111100	3654-3661)	1
1111100	(MLC),	1
1111100	(adherens	1
1111100	lysate	1
1111100	63:3683-3692,	1
1111100	'-',	1
1111100	carcinoma:	1
1111100	TPA,	1
1111100	erythrocyte	1
1111100	(HN;	1
1111100	post-TGF-beta1	1
1111100	lysates	1
1111100	ERCC2	1
1111100	surface,	1
1111100	White	1
1111100	location,	1
1111100	length,	1
1111100	(high-affinity	1
1111100	Class	1
1111100	X22,	1
1111100	RAD3,	1
1111100	adenovirus	1
1111100	CD44v6,	1
1111100	interval	1
1111100	TRAF-2,	1
1111100	stably	1
1111100	panencephalitis	1
1111100	deoxyribonuclease	1
1111100	SM2,	1
1111100	DNAse	1
1111100	dipropylxanthine	1
1111100	Particle	1
1111100	(also	1
1111100	motif,	1
1111100	W.,	1
1111100	X174	1
1111100	synthase	1
1111100	root	1
1111100	Apc(Min/-)	1
1111100	socialis	1
1111100	S-transferase	1
1111100	DFG10,	1
1111100	ball	1
1111100	leukocytes,	1
1111100	E.,	1
1111100	valve	1
1111100	MRF4,	1
1111100	failing	1
1111100	zymosan	1
1111100	myosins,	1
1111100	1751-2190,	1
1111100	94,000,	1
1111100	Immuno-EM	1
1111100	Mg(2+)	1
1111100	Active,	1
1111100	differed	1
1111100	J	2
1111100	reductase	2
1111100	Biochemistry	2
1111100	heterozygotes	2
1111100	vision	2
1111100	(b)	2
1111100	N.,	2
1111100	kD	2
1111100	New	2
1111100	analytical	2
1111100	rDNA	2
1111100	Evidence	2
1111100	(79.4%)	2
1111100	class	2
1111100	invasive	2
1111100	MEC3,	2
1111100	Profilin	3
1111100	T.,	3
1111100	vs.	3
1111100	&	4
1111100	Nature	4
1111100	+/-	4
1111100	bile	4
1111100	M.	4
1111100	tropomyosin,	5
1111100	x	5
1111100	et	5
1111100	D.	6
1111100	per	9
1111100	J.	11
1111100	when	12
1111100	after	16
1111100	To	20
1111100	A	26
1111100	factor	28
1111100	We	54
1111100	we	84
1111101	hnRNP,	1
1111101	Those	1
1111101	elution	1
1111101	simulation	1
1111101	complementation	1
1111101	third,	1
1111101	adventitial	1
1111101	centrifugation	1
1111101	verprolin-like	1
1111101	electrophoresis:	1
1111101	disorganization	1
1111101	(VSV),	1
1111101	spectra	1
1111101	24	1
1111101	SCID,	1
1111101	rickettsii	1
1111101	(VSV)	1
1111101	neoplastic	1
1111101	filamentation	1
1111101	isoform-specific	1
1111101	inhibitor.	1
1111101	p16(INK4a)	1
1111101	muscle-related	1
1111101	(Chant,	1
1111101	radioresistant	1
1111101	p16INK4,	1
1111101	supernatant	1
1111101	K.	1
1111101	R10E11.1	1
1111101	(SV40)-transformed	1
1111101	authors	1
1111101	undifferentiated	1
1111101	cDNAs,	1
1111101	sizes	1
1111101	paper	1
1111101	(homolog	1
1111101	Location	1
1111101	solutions	1
1111101	16236	1
1111101	amino-acids.	1
1111101	blots	1
1111101	(ERK)	1
1111101	stamen	1
1111101	ORFs	1
1111101	aim	1
1111101	main	1
1111101	patterned	1
1111101	poly(ADP-ribose)	1
1111101	I/LWEQ	1
1111101	A1-adenosine	1
1111101	(MV)	1
1111101	p27Kip1	1
1111101	locomotion	1
1111101	existence	1
1111101	E-cadherin-	1
1111101	CDC55,	1
1111101	review	1
1111101	(RPV)	1
1111101	procedure	1
1111101	borders	1
1111101	metabolism	1
1111101	presence,	1
1111101	posttranslational	1
1111101	serine	2
1111101	type-1	2
1111101	prominent	2
1111101	proximity	2
1111101	thymomas	2
1111101	(BRSV)	2
1111101	infection	2
1111101	AV	2
1111101	measurements	2
1111101	long	2
1111101	enzyme	2
1111101	reciprocal	2
1111101	stages	2
1111101	investigation	2
1111101	Acad.	2
1111101	(MAP	2
1111101	p16	2
1111101	inhibitors	3
1111101	apparent	3
1111101	tumours	4
1111101	40	4
1111101	resulting	4
1111101	phosphoinositide	4
1111101	observations	4
1111101	peptidase	5
1111101	inhibitor,	5
1111101	Herpes	6
1111101	previous	7
1111101	findings	7
1111101	herpes	10
1111101	data	11
1111101	studies	16
1111101	type	30
1111101	inhibitor	31
1111101	results	45
11111100	bridges	1
11111100	is,	1
11111100	hormonally	1
11111100	project	1
11111100	consequently	1
11111100	(V;	1
11111100	running	1
11111100	Newly	1
11111100	resembling	1
11111100	PRP5	1
11111100	p27(Kip1),	1
11111100	helper	1
11111100	produces	1
11111100	salivary	1
11111100	E8	1
11111100	resembles	1
11111100	adenoviral	1
11111100	DUN1	1
11111100	matrix,	1
11111100	toxin	1
11111100	DPB11,	1
11111100	AT-hooks,	1
11111100	(negative-sense),	1
11111100	highest	1
11111100	spatially	1
11111100	group,	1
11111100	impairs	1
11111100	polymerization:	1
11111100	50-100	1
11111100	latrunculin-A	1
11111100	over-expression,	1
11111100	coincided	1
11111100	osteoblast-like	1
11111100	PP2A	1
11111100	I:	1
11111100	suramin	1
11111100	block	1
11111100	equally	1
11111100	displays	1
11111100	below	1
11111100	media	1
11111100	alpha-actinin2	1
11111100	accessory	1
11111100	1-syntrophin	1
11111100	shares	2
11111100	PRT1,	2
11111100	represents	2
11111100	includes	2
11111100	takes	2
11111100	N,	2
11111100	resembled	2
11111100	define	2
11111100	mutants,	2
11111100	Even	2
11111100	S,	2
11111100	(e.g.,	2
11111100	Experiments	2
11111100	dodecyl	2
11111100	helicase-primase,	2
11111100	possessing	2
11111100	network,	2
11111100	homologue	3
11111100	displayed	3
11111100	phase,	4
11111100	being	4
11111100	mediates	4
11111100	forming	4
11111100	controls	4
11111100	microM,	4
11111100	RAD17,	5
11111100	regulates	5
11111100	A1	6
11111100	plays	6
11111100	encodes	13
11111100	has	42
11111100	is	237
11111101	23	1
11111101	[D.R.	1
11111101	phosphatidylinositol-4,	1
11111101	(51-54	1
11111101	bands,	1
11111101	99,000,	1
11111101	Indiana	1
11111101	pathological	1
11111101	85,	1
11111101	underlying	1
11111101	<0.05).	1
11111101	utrophin/dystrophin	1
11111101	UBL1,	1
11111101	Ag,	1
11111101	(3	1
11111101	remains	1
11111101	mmol.L-1	1
11111101	rad52	1
11111101	hepatocytes	1
11111101	p53.	1
11111101	Silencing	1
11111101	SNAP-25,	1
11111101	temporarily	1
11111101	rebind	1
11111101	cells:	1
11111101	producing	1
11111101	polymerisability.	1
11111101	28	1
11111101	radiation	1
11111101	H.,	1
11111101	(yeast	1
11111101	substitution	1
11111101	cortex;	1
11111101	hr)	1
11111101	(Deltap)	1
11111101	(PCNA).	1
11111101	(EC)	1
11111101	I(1)were	1
11111101	(residues	1
11111101	N:	1
11111101	localization,	1
11111101	controversy	1
11111101	proteinase	1
11111101	dimerization.	1
11111101	insoluble	1
11111101	CDC39,	1
11111101	DFG5,	1
11111101	furrows	1
11111101	(PRP5,	1
11111101	involving	2
11111101	depends	2
11111101	specimens.	2
11111101	range	2
11111101	nor	2
11111101	normally	2
11111101	display	3
11111101	alone	5
11111101	was	166
11111101	are	128
11111101	were	124
11111110	follow	1
11111110	sevenfold),	1
11111110	Quantitation	1
11111110	XRCC3,	1
11111110	bind.	1
11111110	delta	1
11111110	travel	1
11111110	evolutionary	1
11111110	phosphorylated.	1
11111110	5%	1
11111110	affecting	1
11111110	known,	1
11111110	replace	1
11111110	30-fold	1
11111110	chemoattractants,	1
11111110	injected	1
11111110	twofold	1
11111110	TNF-R1,	1
11111110	fluorescein-labeled	1
11111110	modify	1
11111110	counteract	1
11111110	F.,	1
11111110	frequently	1
11111110	interdependent,	1
11111110	replication-negative	1
11111110	vitronectin,	1
11111110	substratum,	1
11111110	facilitate	1
11111110	TNFR-1,	1
11111110	specify	1
11111110	initiated,	1
11111110	threefold	1
11111110	226)	1
11111110	occur	1
11111110	depolymerization,	1
11111110	A23187	1
11111110	uncover	1
11111110	label	1
11111110	assays,	1
11111110	65:1203-1212;	1
11111110	destroy	1
11111110	mimic	1
11111110	integrate	1
11111110	CUS1	1
11111110	200-fold	1
11111110	3-fold.	1
11111110	allosteric	1
11111110	answer	1
11111110	statistically	1
11111110	30%	1
11111110	bridged	1
11111110	disassemble	1
11111110	TNF.	1
11111110	originate	1
11111110	fluctuations	1
11111110	TNFalpha-induced	1
11111110	4484-4488).	1
11111110	depolymerize	1
11111110	EC	1
11111110	examined,	1
11111110	Mg-ATP.	1
11111110	threefold),	1
11111110	perturb	1
11111110	Trp104-Met115	1
11111110	devoid	1
11111110	supply	1
11111110	polymerize,	1
11111110	create	1
11111110	recognize	1
11111110	kD)	1
11111110	results.	1
11111110	rescue	1
11111110	TSH,	1
11111110	CD44s,	1
11111110	reconstitute	1
11111110	predominate	1
11111110	exercise	1
11111110	compose	1
11111110	enhance	1
11111110	steer	1
11111110	store	1
11111110	overcome	1
11111110	displace	1
11111110	28S	1
11111110	ended	1
11111110	obtain	1
11111110	polymerize	1
11111110	bring	1
11111110	SIR1,	1
11111110	parallels	1
11111110	95%	1
11111110	TIF34.	1
11111110	5.2.	1
11111110	environmental	1
11111110	echinoid	1
11111110	continue	1
11111110	assess	1
11111110	authentic	2
11111110	changing	2
11111110	yield	2
11111110	desmin.	2
11111110	selectively	2
11111110	now	2
11111110	actin-rich	2
11111110	allow	2
11111110	possess	2
11111110	catalyze	2
11111110	examine	2
11111110	help	2
11111110	constitute	3
11111110	co-precipitate	3
11111110	blocks	3
11111110	require	3
11111110	integrins	3
11111110	rodent	3
11111110	activate	3
11111110	vertebrate	3
11111110	retained	3
11111110	sequester	3
11111110	initiate	3
11111110	recruit	3
11111110	disrupt	3
11111110	suppress	3
11111110	accumulate	4
11111110	act	4
11111110	involve	4
11111110	differ	4
11111110	alter	4
11111110	play	4
11111110	stimulate	4
11111110	explain	4
11111110	modulate	4
11111110	assemble	6
11111110	forms	6
11111110	affect	6
11111110	exhibit	6
11111110	promote	6
11111110	induce	6
11111110	mediate	7
11111110	cause	7
11111110	contain	9
11111110	inhibit	9
11111110	those	12
11111110	link	13
11111110	regulate	19
11111110	form	25
11111110	be	66
11111110	bind	34
111111110	10-fold.	1
111111110	APBs	1
111111110	(2.5-fold	1
111111110	MID2	1
111111110	helps	1
111111110	serve	1
111111110	(Arias,	1
111111110	referred	1
111111110	001	1
111111110	belongs	1
111111110	E-APC	1
111111110	coupled	1
111111110	localizes	1
111111110	81	1
111111110	(UL29)	1
111111110	front	1
111111110	AXL1	1
111111110	prior	1
111111110	(estimated	1
111111110	responded	1
111111110	(IL-1alpha)	1
111111110	p21(Cip1/WAF1),	1
111111110	beta,	1
111111110	polymeric	1
111111110	(iv	1
111111110	non-phosphorylated	1
111111110	receptors,	1
111111110	resistant	1
111111110	(16	1
111111110	(ZmPRO5)-induced	1
111111110	protects	1
111111110	prove	1
111111110	Up	1
111111110	weight-lifting	1
111111110	abilities	1
111111110	corresponds	1
111111110	CBP/p300	1
111111110	belong	1
111111110	antipeptide	1
111111110	days	1
111111110	terms	1
111111110	stimulus	1
111111110	myosin:	1
111111110	correspond	1
111111110	HMBA	1
111111110	(ICP8)	1
111111110	cluster	1
111111110	available	2
111111110	simply	2
111111110	contribute	2
111111110	detectably	2
111111110	synergistically	2
111111110	(an	2
111111110	presented	2
111111110	appear	3
111111110	lead	3
111111110	linked	4
111111110	might	4
111111110	appeared	4
111111110	will	4
111111110	thought	4
111111110	leads	5
111111110	cannot	5
111111110	stimulates	5
111111110	links	5
111111110	appears	7
111111110	could	10
111111110	bound	14
111111110	may	36
111111110	can	51
111111110	binds	38
111111111	cancerous	1
111111111	Tumor	1
111111111	partly	1
111111111	calponin	1
111111111	RBC	1
111111111	Yahara,	1
111111111	Claret,	1
111111111	co-precipitated,	1
111111111	VEGF(165),	1
111111111	213	1
111111111	(IC50	1
111111111	Ileal	1
111111111	intimately	1
111111111	down-regulated	1
111111111	RAD	1
111111111	Katagi,	1
111111111	Cell.	1
111111111	which,	1
111111111	none	1
111111111	consistently	1
111111111	capped,	1
111111111	concomitantly	1
111111111	Immunostaining	1
111111111	lacks	1
111111111	J.J.,	1
111111111	M.D.,	1
111111111	E.S.,	1
111111111	once	1
111111111	biosynthetic	1
111111111	([Acc],	1
111111111	Scar,	1
111111111	viscometric	1
111111111	CC,	1
111111111	Gravin	1
111111111	MLH1-mutation	1
111111111	6-22)	1
111111111	lost	1
111111111	already	1
111111111	PRP	1
111111111	retaining	1
111111111	somehow	1
111111111	bacterially	1
111111111	TIF34,	2
111111111	preferentially	2
111111111	transiently	2
111111111	not.	2
111111111	virtually	2
111111111	fit	2
111111111	still	2
111111111	Acanthamoeba,	2
111111111	reconstitution	2
111111111	tightly	2
111111111	ligand,	3
111111111	enriched	3
111111111	generally	3
111111111	simultaneously	3
111111111	there	4
111111111	independently	4
111111111	partially	4
111111111	RAD24,	4
111111111	closely	5
111111111	functionally	6
111111111	without	7
111111111	contrast,	8
111111111	less	9
111111111	directly	11
111111111	not	106
111111111	also	57
